| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Coronary Disease | 162 | 2023 | 6077 | 9.090 |
Why?
|
| Diet | 200 | 2024 | 7937 | 7.280 |
Why?
|
| Alcohol Drinking | 121 | 2023 | 3966 | 6.820 |
Why?
|
| Food Services | 19 | 2023 | 192 | 6.200 |
Why?
|
| Food Preferences | 23 | 2023 | 399 | 5.630 |
Why?
|
| Fruit | 54 | 2023 | 1142 | 5.520 |
Why?
|
| Vegetables | 52 | 2023 | 1182 | 4.700 |
Why?
|
| Cardiovascular Diseases | 164 | 2024 | 15160 | 4.530 |
Why?
|
| Feeding Behavior | 78 | 2022 | 3188 | 4.040 |
Why?
|
| Flavonoids | 23 | 2023 | 443 | 3.710 |
Why?
|
| Food Supply | 20 | 2023 | 524 | 3.620 |
Why?
|
| Life Style | 83 | 2024 | 3835 | 3.400 |
Why?
|
| Food Labeling | 10 | 2023 | 178 | 3.100 |
Why?
|
| Schools | 16 | 2021 | 1433 | 3.060 |
Why?
|
| Beverages | 25 | 2023 | 821 | 2.960 |
Why?
|
| Prospective Studies | 432 | 2023 | 53290 | 2.710 |
Why?
|
| Haptoglobins | 10 | 2024 | 165 | 2.670 |
Why?
|
| Diabetes Mellitus, Type 2 | 105 | 2024 | 11726 | 2.640 |
Why?
|
| Myocardial Infarction | 74 | 2023 | 11718 | 2.500 |
Why?
|
| Risk Factors | 429 | 2023 | 72296 | 2.450 |
Why?
|
| Food | 21 | 2024 | 772 | 2.450 |
Why?
|
| Nutrition Policy | 21 | 2021 | 488 | 2.380 |
Why?
|
| Nutritive Value | 13 | 2022 | 339 | 2.320 |
Why?
|
| Exercise | 66 | 2023 | 5615 | 2.220 |
Why?
|
| Middle Aged | 624 | 2023 | 213390 | 2.170 |
Why?
|
| Homocysteine | 18 | 2015 | 647 | 2.110 |
Why?
|
| Body Mass Index | 127 | 2023 | 12721 | 2.090 |
Why?
|
| Dietary Fats | 50 | 2019 | 2016 | 2.090 |
Why?
|
| Adult | 562 | 2024 | 214052 | 2.020 |
Why?
|
| Follow-Up Studies | 247 | 2023 | 39052 | 2.010 |
Why?
|
| Diet Surveys | 44 | 2024 | 1173 | 1.990 |
Why?
|
| Dietary Fiber | 34 | 2021 | 760 | 1.950 |
Why?
|
| Cholesterol, HDL | 34 | 2023 | 1813 | 1.880 |
Why?
|
| Lignans | 8 | 2022 | 81 | 1.870 |
Why?
|
| Humans | 921 | 2024 | 744366 | 1.860 |
Why?
|
| Nurses | 44 | 2023 | 2462 | 1.830 |
Why?
|
| Energy Intake | 42 | 2023 | 2148 | 1.820 |
Why?
|
| Erectile Dysfunction | 11 | 2022 | 461 | 1.790 |
Why?
|
| Male | 598 | 2024 | 350115 | 1.730 |
Why?
|
| Anthocyanins | 11 | 2024 | 79 | 1.730 |
Why?
|
| Adiponectin | 24 | 2023 | 1101 | 1.720 |
Why?
|
| Aged | 460 | 2023 | 163288 | 1.670 |
Why?
|
| Nutrition Surveys | 28 | 2022 | 1660 | 1.670 |
Why?
|
| Weight Gain | 27 | 2023 | 2293 | 1.670 |
Why?
|
| Seafood | 14 | 2021 | 384 | 1.650 |
Why?
|
| United States | 281 | 2023 | 69872 | 1.650 |
Why?
|
| Female | 545 | 2024 | 380193 | 1.630 |
Why?
|
| Obesity | 73 | 2023 | 12746 | 1.550 |
Why?
|
| Fatty Acids, Omega-3 | 22 | 2023 | 1344 | 1.540 |
Why?
|
| Folic Acid | 27 | 2015 | 1300 | 1.530 |
Why?
|
| Poverty | 17 | 2022 | 2660 | 1.520 |
Why?
|
| Health Promotion | 15 | 2021 | 2205 | 1.500 |
Why?
|
| Dietary Proteins | 16 | 2021 | 963 | 1.490 |
Why?
|
| Cohort Studies | 213 | 2023 | 40559 | 1.470 |
Why?
|
| Risk Reduction Behavior | 16 | 2021 | 1125 | 1.470 |
Why?
|
| Dietary Carbohydrates | 21 | 2023 | 905 | 1.460 |
Why?
|
| Fast Foods | 9 | 2023 | 197 | 1.430 |
Why?
|
| Proportional Hazards Models | 95 | 2023 | 12356 | 1.420 |
Why?
|
| Cause of Death | 29 | 2023 | 3582 | 1.390 |
Why?
|
| Marketing | 8 | 2023 | 212 | 1.380 |
Why?
|
| Incidence | 158 | 2023 | 20952 | 1.370 |
Why?
|
| Health Behavior | 21 | 2022 | 2635 | 1.350 |
Why?
|
| C-Reactive Protein | 31 | 2022 | 3778 | 1.340 |
Why?
|
| Polymorphism, Genetic | 23 | 2014 | 4328 | 1.310 |
Why?
|
| Students | 11 | 2023 | 1647 | 1.260 |
Why?
|
| Nutritional Status | 17 | 2022 | 1609 | 1.240 |
Why?
|
| Smoking | 82 | 2022 | 8987 | 1.210 |
Why?
|
| Milk | 3 | 2019 | 450 | 1.200 |
Why?
|
| Leisure Activities | 6 | 2022 | 311 | 1.200 |
Why?
|
| 1-Alkyl-2-acetylglycerophosphocholine Esterase | 5 | 2014 | 127 | 1.170 |
Why?
|
| Dietary Supplements | 25 | 2019 | 3296 | 1.150 |
Why?
|
| Health Personnel | 63 | 2021 | 3219 | 1.150 |
Why?
|
| Methylamines | 5 | 2021 | 123 | 1.140 |
Why?
|
| Meat | 14 | 2021 | 592 | 1.140 |
Why?
|
| Stroke | 37 | 2023 | 9981 | 1.110 |
Why?
|
| Restaurants | 11 | 2023 | 236 | 1.110 |
Why?
|
| Fishes | 18 | 2021 | 569 | 1.110 |
Why?
|
| Family Characteristics | 10 | 2023 | 1000 | 1.100 |
Why?
|
| Hypertension | 45 | 2023 | 8479 | 1.100 |
Why?
|
| Multivariate Analysis | 94 | 2020 | 12244 | 1.100 |
Why?
|
| Case-Control Studies | 82 | 2021 | 21748 | 1.090 |
Why?
|
| Wine | 13 | 2023 | 165 | 1.050 |
Why?
|
| United States Department of Agriculture | 6 | 2019 | 48 | 1.050 |
Why?
|
| Health Surveys | 23 | 2020 | 4036 | 1.050 |
Why?
|
| Commerce | 8 | 2023 | 592 | 1.040 |
Why?
|
| Cooking | 6 | 2019 | 313 | 1.030 |
Why?
|
| Risk | 84 | 2020 | 9688 | 1.030 |
Why?
|
| Genetic Loci | 13 | 2017 | 2575 | 1.010 |
Why?
|
| Mortality | 17 | 2022 | 2864 | 0.980 |
Why?
|
| Vitamin E | 20 | 2016 | 869 | 0.960 |
Why?
|
| Diet Records | 20 | 2024 | 425 | 0.960 |
Why?
|
| Hypercholesterolemia | 19 | 2022 | 1151 | 0.950 |
Why?
|
| Mendelian Randomization Analysis | 9 | 2020 | 967 | 0.940 |
Why?
|
| Flavanones | 7 | 2016 | 71 | 0.940 |
Why?
|
| School Health Services | 5 | 2023 | 375 | 0.930 |
Why?
|
| Stress Disorders, Post-Traumatic | 19 | 2023 | 4266 | 0.930 |
Why?
|
| Genome-Wide Association Study | 33 | 2023 | 12262 | 0.920 |
Why?
|
| Motor Activity | 15 | 2018 | 2715 | 0.900 |
Why?
|
| Nails | 10 | 2014 | 292 | 0.900 |
Why?
|
| Polymorphism, Single Nucleotide | 53 | 2019 | 15520 | 0.890 |
Why?
|
| Trans Fatty Acids | 8 | 2016 | 153 | 0.890 |
Why?
|
| Ascorbic Acid | 15 | 2022 | 651 | 0.880 |
Why?
|
| Diet, Mediterranean | 12 | 2023 | 700 | 0.880 |
Why?
|
| Leptin | 10 | 2023 | 1600 | 0.880 |
Why?
|
| Receptors, Tumor Necrosis Factor | 11 | 2014 | 595 | 0.870 |
Why?
|
| Alcoholic Beverages | 11 | 2023 | 265 | 0.860 |
Why?
|
| Antioxidants | 20 | 2016 | 1659 | 0.850 |
Why?
|
| Genotype | 41 | 2018 | 12952 | 0.850 |
Why?
|
| Sodium, Dietary | 4 | 2021 | 418 | 0.850 |
Why?
|
| Receptors, Tumor Necrosis Factor, Type II | 12 | 2022 | 357 | 0.840 |
Why?
|
| Body Weight | 24 | 2023 | 4671 | 0.820 |
Why?
|
| Ethanol | 12 | 2021 | 1342 | 0.820 |
Why?
|
| Choice Behavior | 9 | 2023 | 802 | 0.820 |
Why?
|
| Carotenoids | 16 | 2016 | 624 | 0.800 |
Why?
|
| Carbohydrates | 3 | 2023 | 394 | 0.790 |
Why?
|
| Diet, Vegetarian | 8 | 2022 | 174 | 0.790 |
Why?
|
| Selenium | 7 | 2014 | 405 | 0.790 |
Why?
|
| Solanum tuberosum | 5 | 2021 | 37 | 0.790 |
Why?
|
| Methylenetetrahydrofolate Reductase (NADPH2) | 7 | 2011 | 284 | 0.780 |
Why?
|
| Risk Assessment | 66 | 2022 | 23336 | 0.770 |
Why?
|
| Genetic Predisposition to Disease | 43 | 2019 | 17446 | 0.770 |
Why?
|
| Triglycerides | 15 | 2021 | 2453 | 0.760 |
Why?
|
| Coronary Artery Disease | 13 | 2024 | 6486 | 0.760 |
Why?
|
| alpha-Linolenic Acid | 11 | 2016 | 144 | 0.760 |
Why?
|
| Fatty Acids, Omega-6 | 8 | 2023 | 227 | 0.750 |
Why?
|
| American Heart Association | 5 | 2021 | 1057 | 0.740 |
Why?
|
| Food Analysis | 5 | 2021 | 104 | 0.740 |
Why?
|
| C-Peptide | 9 | 2023 | 419 | 0.740 |
Why?
|
| Nutrition Assessment | 22 | 2022 | 723 | 0.730 |
Why?
|
| Waist Circumference | 8 | 2021 | 917 | 0.730 |
Why?
|
| Lipids | 23 | 2023 | 3307 | 0.730 |
Why?
|
| Diet Therapy | 2 | 2021 | 154 | 0.720 |
Why?
|
| Survivors | 4 | 2014 | 2291 | 0.720 |
Why?
|
| Primary Prevention | 6 | 2020 | 1167 | 0.710 |
Why?
|
| Insulin | 16 | 2022 | 6582 | 0.710 |
Why?
|
| Fatty Acids, Unsaturated | 10 | 2023 | 546 | 0.710 |
Why?
|
| Longitudinal Studies | 53 | 2023 | 13991 | 0.700 |
Why?
|
| Soy Milk | 1 | 2019 | 5 | 0.700 |
Why?
|
| Public Assistance | 1 | 2019 | 47 | 0.690 |
Why?
|
| Inflammation | 25 | 2023 | 10637 | 0.680 |
Why?
|
| Cross-Sectional Studies | 60 | 2023 | 25039 | 0.670 |
Why?
|
| Food Contamination | 5 | 2019 | 188 | 0.670 |
Why?
|
| Flavoring Agents | 1 | 2019 | 52 | 0.670 |
Why?
|
| Overweight | 14 | 2023 | 2371 | 0.660 |
Why?
|
| Genetic Variation | 17 | 2019 | 6542 | 0.660 |
Why?
|
| Coffee | 12 | 2023 | 578 | 0.660 |
Why?
|
| Genetic Pleiotropy | 1 | 2019 | 182 | 0.640 |
Why?
|
| Daucus carota | 1 | 2017 | 10 | 0.640 |
Why?
|
| Food-Processing Industry | 1 | 2017 | 15 | 0.630 |
Why?
|
| Isoflavones | 4 | 2022 | 139 | 0.630 |
Why?
|
| Cholesterol | 19 | 2023 | 2919 | 0.630 |
Why?
|
| Cardiovascular System | 4 | 2023 | 831 | 0.620 |
Why?
|
| Methylmercury Compounds | 3 | 2012 | 96 | 0.620 |
Why?
|
| Cholesterol, LDL | 13 | 2021 | 2355 | 0.610 |
Why?
|
| Personnel, Hospital | 4 | 2021 | 283 | 0.610 |
Why?
|
| Eating | 14 | 2023 | 1536 | 0.600 |
Why?
|
| Diet, Carbohydrate-Restricted | 4 | 2023 | 262 | 0.590 |
Why?
|
| Vascular Cell Adhesion Molecule-1 | 6 | 2017 | 707 | 0.580 |
Why?
|
| Dairy Products | 11 | 2020 | 498 | 0.580 |
Why?
|
| Beer | 9 | 2023 | 127 | 0.580 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 7 | 2005 | 1677 | 0.570 |
Why?
|
| Dietary Fats, Unsaturated | 8 | 2017 | 226 | 0.570 |
Why?
|
| Apolipoproteins B | 9 | 2013 | 374 | 0.570 |
Why?
|
| Phospholipids | 7 | 2015 | 784 | 0.560 |
Why?
|
| Nuts | 4 | 2019 | 257 | 0.550 |
Why?
|
| Heart Diseases | 8 | 2022 | 2789 | 0.540 |
Why?
|
| Poultry | 2 | 2016 | 82 | 0.540 |
Why?
|
| Neoplasms | 36 | 2023 | 21696 | 0.540 |
Why?
|
| Child | 44 | 2023 | 77709 | 0.540 |
Why?
|
| Women's Health | 9 | 2018 | 2034 | 0.540 |
Why?
|
| Alcohol Dehydrogenase | 5 | 2014 | 119 | 0.540 |
Why?
|
| Plant Oils | 6 | 2014 | 202 | 0.540 |
Why?
|
| Body Composition | 9 | 2018 | 2402 | 0.530 |
Why?
|
| Food, Organic | 1 | 2015 | 34 | 0.530 |
Why?
|
| Television | 6 | 2019 | 409 | 0.530 |
Why?
|
| 4-Butyrolactone | 3 | 2022 | 63 | 0.520 |
Why?
|
| Aged, 80 and over | 69 | 2021 | 57776 | 0.520 |
Why?
|
| Interleukin-6 | 11 | 2022 | 3203 | 0.520 |
Why?
|
| Spectrometry, Fluorescence | 2 | 2007 | 688 | 0.510 |
Why?
|
| Preventive Health Services | 3 | 2016 | 575 | 0.510 |
Why?
|
| Mercury | 4 | 2012 | 285 | 0.500 |
Why?
|
| Logistic Models | 46 | 2019 | 13409 | 0.500 |
Why?
|
| Age Distribution | 20 | 2015 | 2902 | 0.500 |
Why?
|
| Time Factors | 54 | 2021 | 40075 | 0.500 |
Why?
|
| Flavonols | 9 | 2020 | 83 | 0.500 |
Why?
|
| Self Report | 17 | 2022 | 3553 | 0.490 |
Why?
|
| Waste Products | 1 | 2014 | 12 | 0.490 |
Why?
|
| Health Status | 12 | 2022 | 4034 | 0.490 |
Why?
|
| Video Games | 1 | 2016 | 184 | 0.480 |
Why?
|
| Suicide | 7 | 2011 | 1474 | 0.480 |
Why?
|
| Flavones | 7 | 2020 | 66 | 0.470 |
Why?
|
| Adolescent | 52 | 2023 | 85779 | 0.470 |
Why?
|
| Phytosterols | 2 | 2023 | 64 | 0.460 |
Why?
|
| Colorectal Neoplasms | 16 | 2023 | 6773 | 0.460 |
Why?
|
| Chronic Disease | 19 | 2022 | 9145 | 0.450 |
Why?
|
| Hypertension, Pregnancy-Induced | 4 | 2022 | 489 | 0.450 |
Why?
|
| Massachusetts | 16 | 2022 | 8662 | 0.450 |
Why?
|
| Confidence Intervals | 19 | 2018 | 2971 | 0.450 |
Why?
|
| Vitamin B Complex | 6 | 2015 | 288 | 0.450 |
Why?
|
| Blood Glucose | 15 | 2021 | 6254 | 0.450 |
Why?
|
| Sex Factors | 29 | 2021 | 10400 | 0.440 |
Why?
|
| Docosahexaenoic Acids | 7 | 2023 | 875 | 0.440 |
Why?
|
| Weight Loss | 9 | 2024 | 2625 | 0.440 |
Why?
|
| Epidemiologic Studies | 7 | 2022 | 676 | 0.430 |
Why?
|
| Fatty Acids | 9 | 2018 | 1809 | 0.430 |
Why?
|
| Odds Ratio | 37 | 2019 | 9849 | 0.430 |
Why?
|
| Micronutrients | 4 | 2022 | 375 | 0.430 |
Why?
|
| Aging | 14 | 2017 | 8664 | 0.420 |
Why?
|
| Betaine | 2 | 2014 | 87 | 0.420 |
Why?
|
| Choline | 3 | 2021 | 493 | 0.420 |
Why?
|
| Age Factors | 45 | 2021 | 18373 | 0.410 |
Why?
|
| Lipoproteins, LDL | 4 | 2013 | 640 | 0.410 |
Why?
|
| Lipoproteins, HDL | 5 | 2020 | 638 | 0.410 |
Why?
|
| Pyridoxine | 6 | 2001 | 102 | 0.410 |
Why?
|
| Walking | 5 | 2020 | 1180 | 0.410 |
Why?
|
| Behavior, Addictive | 2 | 2016 | 462 | 0.410 |
Why?
|
| Diabetes Mellitus | 17 | 2023 | 5749 | 0.400 |
Why?
|
| Plant Extracts | 2 | 2015 | 471 | 0.400 |
Why?
|
| Young Adult | 36 | 2023 | 56429 | 0.400 |
Why?
|
| Tea | 9 | 2023 | 275 | 0.400 |
Why?
|
| Inflammation Mediators | 6 | 2021 | 1888 | 0.400 |
Why?
|
| Maine | 3 | 2021 | 139 | 0.390 |
Why?
|
| Procollagen | 4 | 2015 | 185 | 0.390 |
Why?
|
| Vitamin D | 12 | 2017 | 3224 | 0.390 |
Why?
|
| Refuse Disposal | 2 | 2022 | 31 | 0.390 |
Why?
|
| Epidemiologic Methods | 9 | 2019 | 1364 | 0.380 |
Why?
|
| Feces | 5 | 2021 | 1401 | 0.380 |
Why?
|
| Receptors, Tumor Necrosis Factor, Type I | 4 | 2004 | 264 | 0.380 |
Why?
|
| Cholesterol Ester Transfer Proteins | 3 | 2007 | 110 | 0.380 |
Why?
|
| Brain Ischemia | 9 | 2020 | 3265 | 0.370 |
Why?
|
| Reproducibility of Results | 27 | 2024 | 19905 | 0.370 |
Why?
|
| Linear Models | 21 | 2018 | 5953 | 0.370 |
Why?
|
| Regression Analysis | 30 | 2016 | 6459 | 0.370 |
Why?
|
| Plant Proteins | 2 | 2023 | 364 | 0.370 |
Why?
|
| Health Education | 2 | 2017 | 1056 | 0.360 |
Why?
|
| Systems Biology | 1 | 2013 | 469 | 0.360 |
Why?
|
| Lipase | 6 | 2012 | 314 | 0.360 |
Why?
|
| Prevalence | 32 | 2021 | 15221 | 0.360 |
Why?
|
| Pre-Eclampsia | 4 | 2022 | 1200 | 0.350 |
Why?
|
| Health Occupations | 8 | 2019 | 224 | 0.350 |
Why?
|
| Anthropometry | 14 | 2018 | 1350 | 0.350 |
Why?
|
| Patient Compliance | 3 | 2016 | 2684 | 0.350 |
Why?
|
| Pyridoxal Phosphate | 1 | 2009 | 127 | 0.350 |
Why?
|
| Prostatic Neoplasms | 28 | 2021 | 11126 | 0.340 |
Why?
|
| Adipose Tissue | 11 | 2017 | 3280 | 0.340 |
Why?
|
| Lipoproteins | 5 | 2021 | 878 | 0.340 |
Why?
|
| Myocardial Ischemia | 4 | 2010 | 2148 | 0.340 |
Why?
|
| Aryldialkylphosphatase | 1 | 2009 | 63 | 0.340 |
Why?
|
| Heterozygote | 3 | 2015 | 2804 | 0.340 |
Why?
|
| Death, Sudden, Cardiac | 9 | 2012 | 1541 | 0.340 |
Why?
|
| Sleep | 6 | 2023 | 4622 | 0.340 |
Why?
|
| Health Status Indicators | 1 | 2014 | 970 | 0.340 |
Why?
|
| Lipid Metabolism | 5 | 2020 | 1889 | 0.330 |
Why?
|
| Workplace | 5 | 2023 | 836 | 0.330 |
Why?
|
| Apolipoprotein C-III | 3 | 2017 | 202 | 0.330 |
Why?
|
| Endothelium, Vascular | 8 | 2021 | 4459 | 0.330 |
Why?
|
| Body Constitution | 7 | 2000 | 278 | 0.330 |
Why?
|
| Peripheral Arterial Disease | 6 | 2015 | 1188 | 0.330 |
Why?
|
| Phytotherapy | 1 | 2010 | 298 | 0.320 |
Why?
|
| New England | 4 | 2021 | 1022 | 0.320 |
Why?
|
| Sex Distribution | 11 | 2014 | 2297 | 0.320 |
Why?
|
| Diabetic Angiopathies | 7 | 2012 | 818 | 0.320 |
Why?
|
| Premature Birth | 5 | 2021 | 1721 | 0.320 |
Why?
|
| Lipotropic Agents | 1 | 2007 | 14 | 0.310 |
Why?
|
| Food Handling | 4 | 2020 | 145 | 0.310 |
Why?
|
| Cell Adhesion Molecules | 3 | 2015 | 1602 | 0.310 |
Why?
|
| Secondary Prevention | 1 | 2014 | 1530 | 0.310 |
Why?
|
| Environmental Exposure | 5 | 2022 | 4232 | 0.310 |
Why?
|
| Menu Planning | 2 | 2021 | 30 | 0.310 |
Why?
|
| Complement Factor H | 2 | 2007 | 110 | 0.310 |
Why?
|
| Caffeine | 9 | 2012 | 699 | 0.300 |
Why?
|
| Pulmonary Embolism | 6 | 2019 | 2375 | 0.300 |
Why?
|
| Protein Interaction Mapping | 1 | 2011 | 627 | 0.300 |
Why?
|
| Executive Function | 1 | 2016 | 1364 | 0.300 |
Why?
|
| Pregnancy Proteins | 1 | 2008 | 229 | 0.300 |
Why?
|
| Marital Status | 4 | 2014 | 437 | 0.300 |
Why?
|
| Galectin 2 | 1 | 2007 | 13 | 0.300 |
Why?
|
| Phenotype | 19 | 2024 | 16367 | 0.300 |
Why?
|
| Parents | 5 | 2022 | 3405 | 0.300 |
Why?
|
| Fructose | 3 | 2023 | 289 | 0.300 |
Why?
|
| Intercellular Adhesion Molecule-1 | 5 | 2018 | 1159 | 0.290 |
Why?
|
| Fibrinogen | 7 | 2015 | 894 | 0.290 |
Why?
|
| Specimen Handling | 3 | 2021 | 694 | 0.290 |
Why?
|
| Lymphotoxin-alpha | 1 | 2007 | 98 | 0.290 |
Why?
|
| Creatinine | 7 | 2015 | 1919 | 0.290 |
Why?
|
| beta Carotene | 11 | 2018 | 527 | 0.290 |
Why?
|
| Community-Acquired Infections | 3 | 2009 | 465 | 0.290 |
Why?
|
| Animals | 39 | 2023 | 168768 | 0.280 |
Why?
|
| Guideline Adherence | 2 | 2016 | 2265 | 0.280 |
Why?
|
| Vasodilator Agents | 1 | 2010 | 976 | 0.280 |
Why?
|
| Public Health | 8 | 2021 | 2602 | 0.270 |
Why?
|
| Statistics, Nonparametric | 7 | 2021 | 2887 | 0.270 |
Why?
|
| Mental Recall | 7 | 2022 | 1206 | 0.270 |
Why?
|
| Glycemic Index | 7 | 2015 | 394 | 0.270 |
Why?
|
| Caregivers | 4 | 2022 | 2095 | 0.270 |
Why?
|
| PPAR gamma | 2 | 2007 | 493 | 0.270 |
Why?
|
| Boston | 13 | 2021 | 9312 | 0.260 |
Why?
|
| Hospitals | 1 | 2019 | 3954 | 0.260 |
Why?
|
| Kidney Calculi | 8 | 2013 | 465 | 0.260 |
Why?
|
| Macular Degeneration | 5 | 2023 | 980 | 0.260 |
Why?
|
| Temperance | 4 | 2010 | 89 | 0.260 |
Why?
|
| Thrombospondins | 1 | 2006 | 198 | 0.260 |
Why?
|
| Cysteine | 1 | 2010 | 873 | 0.260 |
Why?
|
| Predictive Value of Tests | 15 | 2015 | 15078 | 0.260 |
Why?
|
| Gene Frequency | 11 | 2014 | 3587 | 0.250 |
Why?
|
| F2-Isoprostanes | 1 | 2004 | 35 | 0.250 |
Why?
|
| Diabetes Complications | 6 | 2019 | 1359 | 0.250 |
Why?
|
| Endometriosis | 3 | 2018 | 839 | 0.250 |
Why?
|
| Socioeconomic Factors | 10 | 2019 | 7785 | 0.250 |
Why?
|
| Blood Specimen Collection | 2 | 2003 | 246 | 0.250 |
Why?
|
| Malondialdehyde | 1 | 2004 | 105 | 0.250 |
Why?
|
| Adolescent Nutritional Physiological Phenomena | 2 | 2016 | 63 | 0.250 |
Why?
|
| Cholelithiasis | 5 | 2001 | 414 | 0.250 |
Why?
|
| ABO Blood-Group System | 3 | 2012 | 367 | 0.240 |
Why?
|
| Sweetening Agents | 4 | 2023 | 296 | 0.240 |
Why?
|
| Periodontal Diseases | 4 | 2004 | 449 | 0.240 |
Why?
|
| Acute-Phase Proteins | 1 | 2005 | 262 | 0.240 |
Why?
|
| Linoleic Acid | 4 | 2023 | 157 | 0.240 |
Why?
|
| Proteins | 5 | 2015 | 6100 | 0.240 |
Why?
|
| Vitamin B 6 | 5 | 2015 | 237 | 0.240 |
Why?
|
| Hypolipidemic Agents | 2 | 2022 | 604 | 0.240 |
Why?
|
| Models, Genetic | 4 | 2020 | 3493 | 0.240 |
Why?
|
| Carbon Footprint | 1 | 2023 | 15 | 0.240 |
Why?
|
| Sulfur | 2 | 2021 | 166 | 0.230 |
Why?
|
| Arachidonic Acid | 3 | 2023 | 434 | 0.230 |
Why?
|
| Telomere | 1 | 2010 | 910 | 0.230 |
Why?
|
| Food, Fortified | 3 | 2013 | 191 | 0.230 |
Why?
|
| Motivation | 5 | 2022 | 1971 | 0.230 |
Why?
|
| Alcoholism | 2 | 2013 | 1906 | 0.230 |
Why?
|
| ATP-Binding Cassette Transporters | 1 | 2007 | 560 | 0.230 |
Why?
|
| Gallstones | 2 | 2016 | 286 | 0.230 |
Why?
|
| Income | 4 | 2021 | 1913 | 0.230 |
Why?
|
| Internet | 3 | 2022 | 3056 | 0.230 |
Why?
|
| Insulin Resistance | 9 | 2020 | 3864 | 0.230 |
Why?
|
| Transforming Growth Factor beta | 4 | 2015 | 2007 | 0.230 |
Why?
|
| Smoking Cessation | 3 | 2020 | 2071 | 0.230 |
Why?
|
| Central Nervous System Depressants | 2 | 2021 | 167 | 0.230 |
Why?
|
| Blood Pressure | 13 | 2021 | 8551 | 0.230 |
Why?
|
| Child Nutritional Physiological Phenomena | 3 | 2016 | 303 | 0.220 |
Why?
|
| Phobic Disorders | 3 | 2014 | 439 | 0.220 |
Why?
|
| Receptors, CCR5 | 1 | 2005 | 498 | 0.220 |
Why?
|
| Calcium, Dietary | 8 | 2006 | 526 | 0.220 |
Why?
|
| Diet, Fat-Restricted | 3 | 2017 | 320 | 0.220 |
Why?
|
| Reference Values | 8 | 2010 | 4982 | 0.220 |
Why?
|
| Animal Welfare | 1 | 2022 | 22 | 0.220 |
Why?
|
| Occupational Health Services | 2 | 2021 | 154 | 0.220 |
Why?
|
| Atrial Fibrillation | 6 | 2023 | 5035 | 0.220 |
Why?
|
| Sterilization, Tubal | 1 | 2023 | 87 | 0.220 |
Why?
|
| Randomized Controlled Trials as Topic | 16 | 2024 | 9955 | 0.220 |
Why?
|
| Malus | 4 | 2016 | 48 | 0.210 |
Why?
|
| Quality Improvement | 1 | 2017 | 3749 | 0.210 |
Why?
|
| Adenomatous Polyps | 2 | 2021 | 107 | 0.210 |
Why?
|
| Waste Management | 1 | 2022 | 19 | 0.210 |
Why?
|
| Body Height | 8 | 2017 | 1578 | 0.210 |
Why?
|
| Colonic Polyps | 5 | 2021 | 542 | 0.210 |
Why?
|
| Physical Fitness | 5 | 2014 | 732 | 0.210 |
Why?
|
| Biological Specimen Banks | 2 | 2018 | 711 | 0.210 |
Why?
|
| Vitamins | 5 | 2007 | 1623 | 0.210 |
Why?
|
| Uncertainty | 1 | 2007 | 735 | 0.210 |
Why?
|
| Persea | 1 | 2022 | 17 | 0.210 |
Why?
|
| Depression | 7 | 2020 | 7759 | 0.210 |
Why?
|
| Home Nursing | 1 | 2002 | 92 | 0.210 |
Why?
|
| Fragaria | 2 | 2013 | 21 | 0.210 |
Why?
|
| Dietary Sucrose | 3 | 2017 | 246 | 0.210 |
Why?
|
| Receptors, Chemokine | 1 | 2005 | 670 | 0.210 |
Why?
|
| Fasting | 6 | 2014 | 1592 | 0.210 |
Why?
|
| Atherosclerosis | 6 | 2014 | 3444 | 0.210 |
Why?
|
| Meta-Analysis as Topic | 4 | 2013 | 1342 | 0.200 |
Why?
|
| Family Health | 3 | 2003 | 1281 | 0.200 |
Why?
|
| Seasons | 2 | 2018 | 1493 | 0.200 |
Why?
|
| Health | 4 | 2021 | 394 | 0.200 |
Why?
|
| Insulin-Like Growth Factor Binding Protein 3 | 4 | 2017 | 424 | 0.200 |
Why?
|
| Pneumonia | 3 | 2009 | 2133 | 0.200 |
Why?
|
| Infant | 8 | 2022 | 35134 | 0.200 |
Why?
|
| Social Support | 5 | 2017 | 2118 | 0.200 |
Why?
|
| Sulfur-Reducing Bacteria | 1 | 2021 | 16 | 0.200 |
Why?
|
| Mental Health | 3 | 2017 | 3010 | 0.200 |
Why?
|
| Pharmacy | 1 | 2023 | 91 | 0.200 |
Why?
|
| Sulfur Compounds | 1 | 2021 | 31 | 0.200 |
Why?
|
| Fenofibrate | 1 | 2022 | 88 | 0.200 |
Why?
|
| Vitamin B 12 | 8 | 2015 | 527 | 0.200 |
Why?
|
| Air Pollution | 3 | 2022 | 2286 | 0.200 |
Why?
|
| Nitrates | 2 | 2022 | 265 | 0.200 |
Why?
|
| Diverticulitis | 2 | 2021 | 171 | 0.200 |
Why?
|
| Sleep Initiation and Maintenance Disorders | 2 | 2023 | 1004 | 0.200 |
Why?
|
| Random Allocation | 5 | 2022 | 2428 | 0.190 |
Why?
|
| Peptide Fragments | 5 | 2015 | 5096 | 0.190 |
Why?
|
| Program Evaluation | 5 | 2022 | 2488 | 0.190 |
Why?
|
| Lipid Peroxidation | 4 | 2007 | 270 | 0.190 |
Why?
|
| Shellfish | 1 | 2020 | 38 | 0.190 |
Why?
|
| Bacteria | 3 | 2021 | 2115 | 0.190 |
Why?
|
| Energy Metabolism | 5 | 2018 | 2897 | 0.190 |
Why?
|
| Myocardial Revascularization | 2 | 2016 | 841 | 0.190 |
Why?
|
| Life Expectancy | 3 | 2020 | 1184 | 0.190 |
Why?
|
| Acute Coronary Syndrome | 3 | 2013 | 2337 | 0.190 |
Why?
|
| Child, Preschool | 12 | 2022 | 41005 | 0.190 |
Why?
|
| California | 2 | 2022 | 1402 | 0.190 |
Why?
|
| Oxidative Stress | 6 | 2013 | 3084 | 0.180 |
Why?
|
| Arteriosclerosis | 2 | 2003 | 1092 | 0.180 |
Why?
|
| Venous Thromboembolism | 4 | 2019 | 1671 | 0.180 |
Why?
|
| Fatty Acid-Binding Proteins | 2 | 2016 | 300 | 0.180 |
Why?
|
| Prostatic Hyperplasia | 7 | 2000 | 523 | 0.180 |
Why?
|
| Colonic Neoplasms | 9 | 2012 | 2542 | 0.180 |
Why?
|
| Electronic Mail | 2 | 2019 | 213 | 0.180 |
Why?
|
| Herpes Zoster | 1 | 2022 | 264 | 0.180 |
Why?
|
| Environmental Health | 1 | 2022 | 278 | 0.180 |
Why?
|
| Resistin | 2 | 2012 | 170 | 0.180 |
Why?
|
| Forecasting | 5 | 2017 | 2951 | 0.180 |
Why?
|
| Cacao | 3 | 2012 | 98 | 0.180 |
Why?
|
| Restless Legs Syndrome | 2 | 2013 | 228 | 0.180 |
Why?
|
| Prognosis | 19 | 2020 | 29060 | 0.170 |
Why?
|
| Linkage Disequilibrium | 4 | 2010 | 1997 | 0.170 |
Why?
|
| Sports | 4 | 2016 | 688 | 0.170 |
Why?
|
| Comorbidity | 10 | 2018 | 10388 | 0.170 |
Why?
|
| Diabetic Nephropathies | 2 | 2023 | 984 | 0.170 |
Why?
|
| Weights and Measures | 1 | 2019 | 43 | 0.170 |
Why?
|
| Glutathione Peroxidase | 2 | 2014 | 255 | 0.170 |
Why?
|
| Melatonin | 2 | 2016 | 721 | 0.170 |
Why?
|
| Diabetic Neuropathies | 1 | 2023 | 400 | 0.170 |
Why?
|
| Periodontitis | 3 | 2015 | 553 | 0.170 |
Why?
|
| Diabetic Foot | 1 | 2023 | 355 | 0.170 |
Why?
|
| Analysis of Variance | 7 | 2014 | 6366 | 0.170 |
Why?
|
| Pilot Projects | 5 | 2019 | 8319 | 0.170 |
Why?
|
| Fibroblast Growth Factor 2 | 1 | 2001 | 599 | 0.170 |
Why?
|
| Insulin-Like Growth Factor I | 5 | 2017 | 2016 | 0.170 |
Why?
|
| Pancreatic Diseases | 1 | 2001 | 350 | 0.160 |
Why?
|
| Sphingosine N-Acyltransferase | 1 | 2018 | 7 | 0.160 |
Why?
|
| Pesticide Residues | 1 | 2019 | 95 | 0.160 |
Why?
|
| Metagenome | 2 | 2021 | 418 | 0.160 |
Why?
|
| Corneal Diseases | 1 | 2005 | 636 | 0.160 |
Why?
|
| Abdomen | 2 | 2005 | 1118 | 0.160 |
Why?
|
| Beta vulgaris | 1 | 2017 | 7 | 0.160 |
Why?
|
| Adenoma | 10 | 2004 | 2174 | 0.160 |
Why?
|
| Pregnancy | 17 | 2022 | 29144 | 0.160 |
Why?
|
| Quantitative Trait, Heritable | 2 | 2016 | 544 | 0.160 |
Why?
|
| Peripheral Vascular Diseases | 3 | 2008 | 550 | 0.160 |
Why?
|
| Hormone Replacement Therapy | 3 | 2020 | 745 | 0.160 |
Why?
|
| Tooth Loss | 4 | 2004 | 197 | 0.160 |
Why?
|
| Fibroblast Growth Factors | 3 | 2014 | 878 | 0.160 |
Why?
|
| Radioimmunoassay | 3 | 2007 | 919 | 0.150 |
Why?
|
| Parathyroid Hormone | 2 | 2017 | 1800 | 0.150 |
Why?
|
| Bayes Theorem | 3 | 2023 | 2307 | 0.150 |
Why?
|
| Body Fluid Compartments | 1 | 2017 | 52 | 0.150 |
Why?
|
| Catechin | 3 | 2015 | 66 | 0.150 |
Why?
|
| Adiposity | 3 | 2017 | 1806 | 0.150 |
Why?
|
| Nutritional Requirements | 1 | 2019 | 286 | 0.150 |
Why?
|
| Poisons | 1 | 1997 | 34 | 0.150 |
Why?
|
| Molecular Epidemiology | 1 | 2019 | 468 | 0.150 |
Why?
|
| Antihypertensive Agents | 2 | 2007 | 2047 | 0.150 |
Why?
|
| Asparagus Plant | 1 | 2016 | 4 | 0.150 |
Why?
|
| Models, Biological | 4 | 2021 | 9584 | 0.150 |
Why?
|
| Hyperinsulinism | 1 | 2020 | 415 | 0.150 |
Why?
|
| Aortic Aneurysm, Abdominal | 1 | 2007 | 1186 | 0.150 |
Why?
|
| Nutritional Sciences | 1 | 2018 | 137 | 0.150 |
Why?
|
| Alcoholic Intoxication | 1 | 2018 | 188 | 0.140 |
Why?
|
| Urinary Retention | 5 | 1999 | 111 | 0.140 |
Why?
|
| Nutritional Physiological Phenomena | 5 | 2012 | 370 | 0.140 |
Why?
|
| Denmark | 5 | 2021 | 738 | 0.140 |
Why?
|
| Nitroglycerin | 1 | 2017 | 325 | 0.140 |
Why?
|
| Longevity | 1 | 2004 | 1071 | 0.140 |
Why?
|
| Membrane Proteins | 3 | 2015 | 7882 | 0.140 |
Why?
|
| Vitamin D-Binding Protein | 1 | 2017 | 129 | 0.140 |
Why?
|
| Gene Expression Profiling | 5 | 2021 | 9445 | 0.140 |
Why?
|
| Myosins | 1 | 2018 | 409 | 0.140 |
Why?
|
| Benchmarking | 1 | 2023 | 1042 | 0.140 |
Why?
|
| Cystatin C | 2 | 2015 | 250 | 0.140 |
Why?
|
| Plant Roots | 1 | 2016 | 109 | 0.140 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 5 | 2017 | 3873 | 0.140 |
Why?
|
| Thioredoxin Reductase 2 | 1 | 2016 | 25 | 0.140 |
Why?
|
| Water | 3 | 2023 | 1395 | 0.140 |
Why?
|
| Drinking Behavior | 2 | 2011 | 103 | 0.140 |
Why?
|
| Retinol-Binding Proteins, Plasma | 1 | 2016 | 93 | 0.140 |
Why?
|
| Heart Defects, Congenital | 3 | 2018 | 4583 | 0.140 |
Why?
|
| DNA | 3 | 2014 | 7294 | 0.140 |
Why?
|
| Hip Fractures | 3 | 2019 | 955 | 0.140 |
Why?
|
| Acetaminophen | 3 | 2007 | 545 | 0.140 |
Why?
|
| Fatty Acids, Monounsaturated | 1 | 2017 | 194 | 0.140 |
Why?
|
| Plants, Edible | 1 | 2015 | 30 | 0.140 |
Why?
|
| Respiratory Tract Diseases | 1 | 2021 | 722 | 0.130 |
Why?
|
| Metabolomics | 2 | 2023 | 1485 | 0.130 |
Why?
|
| Multifactorial Inheritance | 2 | 2014 | 1195 | 0.130 |
Why?
|
| Internationality | 1 | 2021 | 1002 | 0.130 |
Why?
|
| Postmenopause | 6 | 2014 | 2460 | 0.130 |
Why?
|
| Menopause | 4 | 2016 | 1626 | 0.130 |
Why?
|
| Stillbirth | 1 | 2018 | 346 | 0.130 |
Why?
|
| Fibrosis | 4 | 2015 | 2029 | 0.130 |
Why?
|
| Rural Population | 2 | 2017 | 2207 | 0.130 |
Why?
|
| Puerperal Disorders | 1 | 2018 | 275 | 0.130 |
Why?
|
| Cytochrome P-450 CYP1A2 | 2 | 2014 | 68 | 0.130 |
Why?
|
| Behavior Therapy | 1 | 2021 | 865 | 0.130 |
Why?
|
| Dose-Response Relationship, Drug | 11 | 2016 | 10943 | 0.130 |
Why?
|
| Magnesium | 4 | 2004 | 813 | 0.130 |
Why?
|
| Lipoproteins, VLDL | 2 | 2013 | 201 | 0.130 |
Why?
|
| Endocrine System Diseases | 1 | 2017 | 248 | 0.130 |
Why?
|
| Evidence-Based Medicine | 2 | 2018 | 3611 | 0.130 |
Why?
|
| Tobacco Use Disorder | 2 | 2019 | 688 | 0.130 |
Why?
|
| Waist-Hip Ratio | 2 | 2008 | 517 | 0.130 |
Why?
|
| Urine | 1 | 2016 | 370 | 0.130 |
Why?
|
| Wounds and Injuries | 3 | 2019 | 2400 | 0.130 |
Why?
|
| Lipoprotein(a) | 4 | 2014 | 435 | 0.130 |
Why?
|
| Dyssomnias | 1 | 2014 | 29 | 0.130 |
Why?
|
| Factor VII | 2 | 2006 | 139 | 0.130 |
Why?
|
| Folic Acid Deficiency | 3 | 2012 | 115 | 0.130 |
Why?
|
| Coffea | 1 | 2014 | 22 | 0.130 |
Why?
|
| Metagenomics | 4 | 2021 | 428 | 0.130 |
Why?
|
| Precancerous Conditions | 2 | 2021 | 975 | 0.120 |
Why?
|
| Parity | 4 | 2021 | 929 | 0.120 |
Why?
|
| Resistance Training | 1 | 2017 | 164 | 0.120 |
Why?
|
| Body Size | 1 | 2017 | 461 | 0.120 |
Why?
|
| Biomedical Research | 3 | 2021 | 3309 | 0.120 |
Why?
|
| NF-kappa B p50 Subunit | 2 | 2013 | 107 | 0.120 |
Why?
|
| Arsenic | 1 | 1997 | 328 | 0.120 |
Why?
|
| Seeds | 1 | 2014 | 105 | 0.120 |
Why?
|
| Phosphatidylcholines | 1 | 2016 | 411 | 0.120 |
Why?
|
| Diet, Gluten-Free | 1 | 2017 | 271 | 0.120 |
Why?
|
| Chi-Square Distribution | 4 | 2016 | 3508 | 0.120 |
Why?
|
| Parkinson Disease | 3 | 2016 | 2775 | 0.120 |
Why?
|
| Vitamin A | 4 | 2001 | 615 | 0.120 |
Why?
|
| Norway | 3 | 2020 | 448 | 0.120 |
Why?
|
| Olfaction Disorders | 1 | 2016 | 222 | 0.120 |
Why?
|
| Pancreas | 1 | 2001 | 1687 | 0.120 |
Why?
|
| Catalase | 1 | 2014 | 221 | 0.120 |
Why?
|
| Reimbursement, Incentive | 1 | 2019 | 540 | 0.120 |
Why?
|
| Galectin 3 | 1 | 2016 | 227 | 0.120 |
Why?
|
| Focus Groups | 1 | 2018 | 1321 | 0.120 |
Why?
|
| Phytoestrogens | 2 | 2022 | 61 | 0.120 |
Why?
|
| Residence Characteristics | 3 | 2020 | 2050 | 0.120 |
Why?
|
| Neurodegenerative Diseases | 1 | 2023 | 1061 | 0.120 |
Why?
|
| Models, Cardiovascular | 1 | 2019 | 996 | 0.120 |
Why?
|
| Actigraphy | 1 | 2017 | 488 | 0.120 |
Why?
|
| Diabetic Retinopathy | 1 | 2023 | 1210 | 0.120 |
Why?
|
| Glutamic Acid | 2 | 2023 | 1169 | 0.120 |
Why?
|
| beta 2-Microglobulin | 1 | 2014 | 315 | 0.110 |
Why?
|
| Glutamate-Ammonia Ligase | 1 | 2013 | 74 | 0.110 |
Why?
|
| Drug Utilization | 1 | 2019 | 1183 | 0.110 |
Why?
|
| Plants | 2 | 2019 | 316 | 0.110 |
Why?
|
| Biological Products | 1 | 2022 | 860 | 0.110 |
Why?
|
| Molecular Weight | 2 | 2016 | 2255 | 0.110 |
Why?
|
| Human Characteristics | 1 | 2012 | 7 | 0.110 |
Why?
|
| Alleles | 6 | 2017 | 6933 | 0.110 |
Why?
|
| Abortion, Spontaneous | 1 | 2018 | 544 | 0.110 |
Why?
|
| Apigenin | 2 | 2010 | 14 | 0.110 |
Why?
|
| Vitamin D Deficiency | 2 | 2017 | 1343 | 0.110 |
Why?
|
| Prescription Drugs | 1 | 2020 | 595 | 0.110 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 3 | 2014 | 2282 | 0.110 |
Why?
|
| Serine Endopeptidases | 1 | 2018 | 1073 | 0.110 |
Why?
|
| Urban Population | 3 | 2019 | 2022 | 0.110 |
Why?
|
| zeta-Crystallins | 1 | 2012 | 4 | 0.110 |
Why?
|
| Geography | 2 | 2018 | 669 | 0.110 |
Why?
|
| Severity of Illness Index | 8 | 2017 | 15535 | 0.110 |
Why?
|
| Cholecystectomy | 3 | 2003 | 395 | 0.110 |
Why?
|
| Likelihood Functions | 3 | 2014 | 1005 | 0.110 |
Why?
|
| Proton Pump Inhibitors | 1 | 2017 | 526 | 0.110 |
Why?
|
| Research Design | 5 | 2021 | 5984 | 0.110 |
Why?
|
| Genetic Markers | 3 | 2014 | 2634 | 0.110 |
Why?
|
| Cerebrovascular Disorders | 7 | 1999 | 1504 | 0.110 |
Why?
|
| Particulate Matter | 2 | 2022 | 2529 | 0.110 |
Why?
|
| Spinal Fractures | 1 | 2019 | 696 | 0.110 |
Why?
|
| Geographic Atrophy | 1 | 2013 | 66 | 0.110 |
Why?
|
| Sequence Deletion | 3 | 2013 | 1525 | 0.110 |
Why?
|
| Dyslipidemias | 2 | 2013 | 849 | 0.110 |
Why?
|
| Apolipoproteins E | 2 | 2020 | 1438 | 0.110 |
Why?
|
| Adolescent Behavior | 2 | 2011 | 1151 | 0.110 |
Why?
|
| Heart | 2 | 2023 | 4464 | 0.100 |
Why?
|
| Educational Status | 2 | 2020 | 2540 | 0.100 |
Why?
|
| Haplotypes | 2 | 2009 | 2779 | 0.100 |
Why?
|
| Social Change | 2 | 2010 | 153 | 0.100 |
Why?
|
| Intermittent Claudication | 1 | 2014 | 309 | 0.100 |
Why?
|
| Receptors, Adrenergic, beta-1 | 1 | 2011 | 51 | 0.100 |
Why?
|
| Population Surveillance | 3 | 2016 | 2616 | 0.100 |
Why?
|
| Pregnancy Outcome | 2 | 2020 | 2795 | 0.100 |
Why?
|
| Dehydroepiandrosterone Sulfate | 1 | 2012 | 238 | 0.100 |
Why?
|
| Constipation | 1 | 2016 | 546 | 0.100 |
Why?
|
| Survival Rate | 10 | 2019 | 12788 | 0.100 |
Why?
|
| Sulfotransferases | 1 | 2012 | 151 | 0.100 |
Why?
|
| Superoxide Dismutase | 1 | 2014 | 596 | 0.100 |
Why?
|
| Receptors, Oxytocin | 1 | 2012 | 66 | 0.100 |
Why?
|
| Eicosapentaenoic Acid | 4 | 2023 | 582 | 0.100 |
Why?
|
| Genetic Association Studies | 3 | 2017 | 2703 | 0.100 |
Why?
|
| Anti-Bacterial Agents | 2 | 2019 | 7182 | 0.100 |
Why?
|
| Arrhythmias, Cardiac | 2 | 2013 | 2269 | 0.100 |
Why?
|
| Ovarian Neoplasms | 2 | 2021 | 4839 | 0.100 |
Why?
|
| Vaccinium | 1 | 2010 | 2 | 0.100 |
Why?
|
| Postprandial Period | 2 | 2024 | 292 | 0.100 |
Why?
|
| Birth Weight | 3 | 2011 | 2069 | 0.100 |
Why?
|
| Analgesia, Patient-Controlled | 4 | 1995 | 109 | 0.100 |
Why?
|
| Obesity, Abdominal | 1 | 2014 | 361 | 0.100 |
Why?
|
| Glycine Hydroxymethyltransferase | 1 | 2010 | 32 | 0.100 |
Why?
|
| Chromosomes, Human, Pair 1 | 1 | 2013 | 658 | 0.100 |
Why?
|
| Quality of Life | 2 | 2015 | 12802 | 0.100 |
Why?
|
| Patient Protection and Affordable Care Act | 1 | 2021 | 1209 | 0.100 |
Why?
|
| Promoter Regions, Genetic | 3 | 2013 | 5867 | 0.100 |
Why?
|
| Wet Macular Degeneration | 1 | 2013 | 145 | 0.100 |
Why?
|
| Taste | 1 | 2012 | 176 | 0.100 |
Why?
|
| Up-Regulation | 3 | 2018 | 4222 | 0.100 |
Why?
|
| Carcinoma, Basal Cell | 3 | 2002 | 545 | 0.100 |
Why?
|
| Sex Characteristics | 6 | 2012 | 2585 | 0.090 |
Why?
|
| Acetyltransferases | 1 | 2012 | 234 | 0.090 |
Why?
|
| Disease Progression | 6 | 2017 | 13286 | 0.090 |
Why?
|
| Receptors, Interleukin-6 | 1 | 2012 | 225 | 0.090 |
Why?
|
| Venous Thrombosis | 2 | 2019 | 1239 | 0.090 |
Why?
|
| Widowhood | 2 | 2014 | 54 | 0.090 |
Why?
|
| Solubility | 2 | 2003 | 1088 | 0.090 |
Why?
|
| Estradiol | 2 | 2012 | 2020 | 0.090 |
Why?
|
| Diagnosis, Dual (Psychiatry) | 1 | 2011 | 295 | 0.090 |
Why?
|
| Chromosomes, Human, Pair 7 | 1 | 2011 | 322 | 0.090 |
Why?
|
| Diabetes, Gestational | 2 | 2017 | 1184 | 0.090 |
Why?
|
| Gene Expression Regulation | 2 | 2016 | 12073 | 0.090 |
Why?
|
| Neoplasms, Glandular and Epithelial | 1 | 2014 | 484 | 0.090 |
Why?
|
| Stress, Psychological | 3 | 2015 | 4245 | 0.090 |
Why?
|
| Fear | 1 | 2019 | 1440 | 0.090 |
Why?
|
| INDEL Mutation | 1 | 2011 | 279 | 0.090 |
Why?
|
| Veterinary Medicine | 1 | 1989 | 21 | 0.090 |
Why?
|
| Brassica | 3 | 2007 | 38 | 0.090 |
Why?
|
| Contraceptives, Oral | 1 | 1992 | 564 | 0.090 |
Why?
|
| Phosphorus | 1 | 2011 | 338 | 0.090 |
Why?
|
| Sex Hormone-Binding Globulin | 1 | 2012 | 548 | 0.090 |
Why?
|
| Analgesics, Non-Narcotic | 2 | 2007 | 366 | 0.090 |
Why?
|
| Gastrointestinal Tract | 1 | 2016 | 814 | 0.090 |
Why?
|
| Chromosome Mapping | 2 | 2017 | 4740 | 0.090 |
Why?
|
| Estrogen Replacement Therapy | 3 | 2011 | 1203 | 0.090 |
Why?
|
| Costs and Cost Analysis | 2 | 2013 | 1680 | 0.090 |
Why?
|
| Chromosomes, Human, Pair 15 | 1 | 2011 | 373 | 0.090 |
Why?
|
| Feasibility Studies | 2 | 2020 | 5077 | 0.090 |
Why?
|
| Philadelphia | 2 | 2023 | 267 | 0.090 |
Why?
|
| Glycosylation | 1 | 2013 | 1128 | 0.090 |
Why?
|
| Fontan Procedure | 1 | 2016 | 776 | 0.090 |
Why?
|
| Receptors, Leptin | 2 | 2001 | 361 | 0.090 |
Why?
|
| Metabolome | 3 | 2023 | 895 | 0.090 |
Why?
|
| Diarrhea | 1 | 2016 | 1348 | 0.090 |
Why?
|
| Meat Products | 2 | 2017 | 99 | 0.090 |
Why?
|
| Infant, Newborn | 5 | 2022 | 25628 | 0.090 |
Why?
|
| Glaucoma, Open-Angle | 1 | 2016 | 706 | 0.080 |
Why?
|
| Gastrointestinal Diseases | 1 | 2017 | 1170 | 0.080 |
Why?
|
| Models, Statistical | 7 | 2014 | 5101 | 0.080 |
Why?
|
| Parenting | 1 | 2015 | 679 | 0.080 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 1 | 2015 | 1115 | 0.080 |
Why?
|
| Skin Neoplasms | 5 | 2011 | 5692 | 0.080 |
Why?
|
| Survival Analysis | 5 | 2019 | 10252 | 0.080 |
Why?
|
| Quantitative Trait Loci | 4 | 2016 | 2019 | 0.080 |
Why?
|
| Activities of Daily Living | 2 | 2017 | 2419 | 0.080 |
Why?
|
| Drug Users | 1 | 2011 | 134 | 0.080 |
Why?
|
| Homozygote | 4 | 2009 | 1787 | 0.080 |
Why?
|
| Personality | 1 | 2012 | 552 | 0.080 |
Why?
|
| Apolipoprotein A-I | 2 | 2020 | 281 | 0.080 |
Why?
|
| Nevus, Pigmented | 1 | 2011 | 219 | 0.080 |
Why?
|
| Time | 1 | 2010 | 542 | 0.080 |
Why?
|
| Aspirin | 4 | 2010 | 3283 | 0.080 |
Why?
|
| Cyclooxygenase 2 Inhibitors | 2 | 2008 | 320 | 0.080 |
Why?
|
| Retinal Diseases | 1 | 2015 | 684 | 0.080 |
Why?
|
| Eggs | 2 | 2020 | 184 | 0.080 |
Why?
|
| Lipoprotein Lipase | 1 | 2009 | 126 | 0.080 |
Why?
|
| Homeostasis | 1 | 1999 | 3339 | 0.080 |
Why?
|
| Prostatism | 1 | 2008 | 14 | 0.080 |
Why?
|
| Metabolic Diseases | 1 | 2015 | 658 | 0.080 |
Why?
|
| Receptors, Epoprostenol | 1 | 2008 | 12 | 0.080 |
Why?
|
| Vehicle Emissions | 1 | 2013 | 665 | 0.080 |
Why?
|
| Forkhead Transcription Factors | 1 | 2016 | 1613 | 0.080 |
Why?
|
| Carotid Artery Diseases | 1 | 2015 | 879 | 0.080 |
Why?
|
| Soybean Proteins | 1 | 2008 | 61 | 0.080 |
Why?
|
| Hysterectomy | 3 | 2023 | 927 | 0.080 |
Why?
|
| Medical History Taking | 2 | 2010 | 784 | 0.080 |
Why?
|
| Clinical Trials as Topic | 3 | 2018 | 7914 | 0.080 |
Why?
|
| Policy | 2 | 2022 | 508 | 0.080 |
Why?
|
| Testosterone | 3 | 2012 | 2419 | 0.080 |
Why?
|
| Healthcare Disparities | 2 | 2016 | 3154 | 0.080 |
Why?
|
| Interviews as Topic | 1 | 2015 | 2539 | 0.080 |
Why?
|
| Monitoring, Physiologic | 1 | 2015 | 1739 | 0.080 |
Why?
|
| Repetitive Sequences, Nucleic Acid | 1 | 2010 | 798 | 0.080 |
Why?
|
| Toes | 3 | 2004 | 206 | 0.080 |
Why?
|
| Air Pollutants | 1 | 2022 | 2816 | 0.080 |
Why?
|
| Oxidoreductases Acting on CH-NH Group Donors | 2 | 1998 | 63 | 0.080 |
Why?
|
| Chromosomes, Human, Pair 9 | 1 | 2009 | 535 | 0.080 |
Why?
|
| Antigens, CD | 3 | 2004 | 4026 | 0.080 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2018 | 2850 | 0.080 |
Why?
|
| Diabetes Mellitus, Type 1 | 1 | 2002 | 3338 | 0.080 |
Why?
|
| Dioxins | 1 | 2008 | 102 | 0.080 |
Why?
|
| E-Selectin | 1 | 2010 | 579 | 0.080 |
Why?
|
| Drug Interactions | 4 | 2005 | 1460 | 0.080 |
Why?
|
| Hypoglycemic Agents | 1 | 2020 | 2873 | 0.080 |
Why?
|
| NF-kappa B | 2 | 2013 | 2499 | 0.080 |
Why?
|
| Ovariectomy | 2 | 2023 | 661 | 0.080 |
Why?
|
| Hypertriglyceridemia | 2 | 2011 | 293 | 0.070 |
Why?
|
| Thrombosis | 1 | 2001 | 2968 | 0.070 |
Why?
|
| Urinary Bladder Neoplasms | 4 | 2001 | 2249 | 0.070 |
Why?
|
| Kaempferols | 2 | 2007 | 21 | 0.070 |
Why?
|
| Psychiatric Status Rating Scales | 2 | 2016 | 6036 | 0.070 |
Why?
|
| Sodium | 2 | 2023 | 1622 | 0.070 |
Why?
|
| Duodenal Ulcer | 2 | 1997 | 125 | 0.070 |
Why?
|
| Hearing Loss | 1 | 2014 | 765 | 0.070 |
Why?
|
| Gene Expression | 2 | 2018 | 7798 | 0.070 |
Why?
|
| Mercury Poisoning | 1 | 2006 | 33 | 0.070 |
Why?
|
| Attitude | 1 | 2012 | 776 | 0.070 |
Why?
|
| Leukocytes | 2 | 2017 | 2045 | 0.070 |
Why?
|
| Sensitivity and Specificity | 7 | 2015 | 14723 | 0.070 |
Why?
|
| Riboflavin | 3 | 2015 | 108 | 0.070 |
Why?
|
| Glioma | 1 | 2021 | 3401 | 0.070 |
Why?
|
| Hydroxycholecalciferols | 1 | 2006 | 44 | 0.070 |
Why?
|
| Vitamin K | 1 | 2008 | 295 | 0.070 |
Why?
|
| Oxidation-Reduction | 2 | 2013 | 2184 | 0.070 |
Why?
|
| Heart Failure | 5 | 2014 | 10895 | 0.070 |
Why?
|
| Glutamine | 2 | 2023 | 579 | 0.070 |
Why?
|
| Cognition | 3 | 2024 | 6770 | 0.070 |
Why?
|
| Methylation | 2 | 2007 | 1106 | 0.070 |
Why?
|
| Statistics as Topic | 4 | 2017 | 2373 | 0.070 |
Why?
|
| Sodium Channels | 1 | 2007 | 349 | 0.070 |
Why?
|
| Calcium | 3 | 2014 | 5755 | 0.070 |
Why?
|
| Fetal Development | 1 | 2011 | 767 | 0.070 |
Why?
|
| Citrus | 3 | 2013 | 41 | 0.070 |
Why?
|
| Cardiology | 1 | 1997 | 1668 | 0.070 |
Why?
|
| Methionine | 4 | 1998 | 590 | 0.070 |
Why?
|
| Decision Support Techniques | 1 | 2015 | 1956 | 0.070 |
Why?
|
| Epidemiology | 1 | 2008 | 287 | 0.070 |
Why?
|
| Diverticulum, Colon | 2 | 1995 | 33 | 0.060 |
Why?
|
| Diverticulum | 2 | 1998 | 136 | 0.060 |
Why?
|
| Life Change Events | 3 | 2021 | 938 | 0.060 |
Why?
|
| Costa Rica | 3 | 2012 | 177 | 0.060 |
Why?
|
| Kidney Function Tests | 1 | 2007 | 683 | 0.060 |
Why?
|
| Affect | 1 | 2013 | 1475 | 0.060 |
Why?
|
| Proto-Oncogene Proteins c-met | 2 | 1999 | 578 | 0.060 |
Why?
|
| Divorce | 1 | 2005 | 79 | 0.060 |
Why?
|
| Tobacco Smoke Pollution | 1 | 2011 | 816 | 0.060 |
Why?
|
| Cross-Cultural Comparison | 2 | 2001 | 651 | 0.060 |
Why?
|
| Kidney | 3 | 2006 | 7184 | 0.060 |
Why?
|
| Receptors, CCR2 | 1 | 2005 | 212 | 0.060 |
Why?
|
| Physical Endurance | 3 | 2013 | 370 | 0.060 |
Why?
|
| Taiwan | 3 | 2000 | 496 | 0.060 |
Why?
|
| Sampling Studies | 2 | 2004 | 623 | 0.060 |
Why?
|
| Fish Oils | 2 | 2005 | 470 | 0.060 |
Why?
|
| Emotions | 2 | 2013 | 2659 | 0.060 |
Why?
|
| Bread | 1 | 2023 | 23 | 0.060 |
Why?
|
| Carcinogens | 1 | 2006 | 466 | 0.060 |
Why?
|
| Receptor, Melanocortin, Type 4 | 2 | 2015 | 129 | 0.060 |
Why?
|
| Drinking | 3 | 2001 | 197 | 0.060 |
Why?
|
| Chromium | 1 | 2004 | 123 | 0.060 |
Why?
|
| Psoriasis | 1 | 2012 | 902 | 0.060 |
Why?
|
| Migraine Disorders | 1 | 2016 | 1620 | 0.060 |
Why?
|
| Citrus sinensis | 2 | 2014 | 16 | 0.060 |
Why?
|
| Anticarcinogenic Agents | 2 | 2003 | 253 | 0.060 |
Why?
|
| Thiamine | 1 | 2004 | 152 | 0.060 |
Why?
|
| Vascular Diseases | 2 | 2003 | 1161 | 0.060 |
Why?
|
| Wrist Injuries | 2 | 1998 | 208 | 0.060 |
Why?
|
| Blood Preservation | 1 | 2004 | 177 | 0.060 |
Why?
|
| Causality | 5 | 2016 | 1275 | 0.060 |
Why?
|
| Ice | 1 | 2004 | 104 | 0.060 |
Why?
|
| Monosaccharides | 1 | 2023 | 70 | 0.060 |
Why?
|
| Accidents | 2 | 2002 | 164 | 0.060 |
Why?
|
| Food Industry | 1 | 2003 | 68 | 0.060 |
Why?
|
| Erythrocyte Membrane | 1 | 2004 | 442 | 0.060 |
Why?
|
| Clinical Laboratory Techniques | 1 | 2008 | 738 | 0.060 |
Why?
|
| Kynurenine | 1 | 2023 | 139 | 0.060 |
Why?
|
| Hematinics | 1 | 2006 | 280 | 0.060 |
Why?
|
| ROC Curve | 1 | 2011 | 3528 | 0.060 |
Why?
|
| Tumor Necrosis Factor-alpha | 3 | 2023 | 4424 | 0.050 |
Why?
|
| Dental Amalgam | 1 | 2003 | 67 | 0.050 |
Why?
|
| Polymerase Chain Reaction | 2 | 2010 | 6171 | 0.050 |
Why?
|
| Water Pollutants, Chemical | 1 | 2006 | 311 | 0.050 |
Why?
|
| Dental Caries Susceptibility | 1 | 2022 | 25 | 0.050 |
Why?
|
| Heart Rate | 2 | 2013 | 4092 | 0.050 |
Why?
|
| Chemokine CCL2 | 1 | 2005 | 619 | 0.050 |
Why?
|
| Potassium, Dietary | 3 | 1998 | 96 | 0.050 |
Why?
|
| Coumarins | 1 | 2022 | 119 | 0.050 |
Why?
|
| Chromatography, High Pressure Liquid | 2 | 2004 | 1572 | 0.050 |
Why?
|
| Gallbladder Diseases | 1 | 2003 | 125 | 0.050 |
Why?
|
| Expressed Emotion | 1 | 2003 | 92 | 0.050 |
Why?
|
| Anticholesteremic Agents | 1 | 2010 | 979 | 0.050 |
Why?
|
| Lutein | 5 | 2003 | 125 | 0.050 |
Why?
|
| Data Collection | 2 | 1998 | 3339 | 0.050 |
Why?
|
| Muscle Proteins | 1 | 2007 | 1158 | 0.050 |
Why?
|
| Food Service, Hospital | 1 | 2021 | 15 | 0.050 |
Why?
|
| Plasminogen Activator Inhibitor 1 | 1 | 2023 | 281 | 0.050 |
Why?
|
| Mutation, Missense | 2 | 2008 | 2566 | 0.050 |
Why?
|
| Tryptophan | 1 | 2023 | 478 | 0.050 |
Why?
|
| Fusobacterium | 1 | 2021 | 54 | 0.050 |
Why?
|
| Pancreatitis, Alcoholic | 1 | 2001 | 30 | 0.050 |
Why?
|
| Eicosanoids | 1 | 2003 | 279 | 0.050 |
Why?
|
| Cardiac Surgical Procedures | 1 | 2016 | 3537 | 0.050 |
Why?
|
| Neoplasm Staging | 7 | 2019 | 11031 | 0.050 |
Why?
|
| Prostate-Specific Antigen | 2 | 2003 | 2494 | 0.050 |
Why?
|
| Prebiotics | 1 | 2021 | 44 | 0.050 |
Why?
|
| Methylmalonic Acid | 1 | 2001 | 49 | 0.050 |
Why?
|
| Sickness Impact Profile | 1 | 2002 | 302 | 0.050 |
Why?
|
| Child Development | 1 | 2013 | 2223 | 0.050 |
Why?
|
| Double-Blind Method | 4 | 2021 | 12025 | 0.050 |
Why?
|
| Taxes | 1 | 2023 | 221 | 0.050 |
Why?
|
| Nova Scotia | 1 | 2020 | 34 | 0.050 |
Why?
|
| DNA Methylation | 1 | 2015 | 4285 | 0.050 |
Why?
|
| Prevotella | 1 | 2021 | 79 | 0.050 |
Why?
|
| Potassium | 2 | 2021 | 1336 | 0.050 |
Why?
|
| Bifidobacterium | 1 | 2021 | 100 | 0.050 |
Why?
|
| Ventricular Dysfunction, Left | 1 | 2012 | 2073 | 0.050 |
Why?
|
| Databases, Factual | 3 | 2013 | 7730 | 0.050 |
Why?
|
| Treatment Outcome | 8 | 2016 | 63107 | 0.050 |
Why?
|
| Netherlands | 3 | 2015 | 2170 | 0.050 |
Why?
|
| Zinc | 2 | 2004 | 684 | 0.050 |
Why?
|
| Social Responsibility | 1 | 2003 | 388 | 0.050 |
Why?
|
| Renal Insufficiency, Chronic | 1 | 2015 | 2200 | 0.050 |
Why?
|
| Europe | 3 | 2014 | 3338 | 0.050 |
Why?
|
| Morbidity | 2 | 2020 | 1768 | 0.050 |
Why?
|
| Carnitine | 1 | 2021 | 246 | 0.050 |
Why?
|
| Onions | 2 | 2014 | 7 | 0.050 |
Why?
|
| Recurrence | 4 | 2018 | 8340 | 0.050 |
Why?
|
| Endometrial Neoplasms | 1 | 2010 | 1351 | 0.050 |
Why?
|
| Preventive Medicine | 1 | 2002 | 264 | 0.050 |
Why?
|
| Anger | 1 | 2003 | 402 | 0.050 |
Why?
|
| Apolipoproteins | 2 | 2019 | 317 | 0.050 |
Why?
|
| Hydrogen Sulfide | 1 | 2021 | 137 | 0.050 |
Why?
|
| Age of Onset | 2 | 2021 | 3270 | 0.050 |
Why?
|
| Membrane Glycoproteins | 1 | 2011 | 3771 | 0.040 |
Why?
|
| von Willebrand Factor | 1 | 2004 | 669 | 0.040 |
Why?
|
| Cheese | 1 | 2019 | 38 | 0.040 |
Why?
|
| Quercetin | 2 | 2015 | 93 | 0.040 |
Why?
|
| Southeastern United States | 1 | 2019 | 95 | 0.040 |
Why?
|
| Carbon | 1 | 2023 | 687 | 0.040 |
Why?
|
| Breast Neoplasms | 7 | 2010 | 20824 | 0.040 |
Why?
|
| Yogurt | 1 | 2019 | 72 | 0.040 |
Why?
|
| Spouses | 1 | 2002 | 286 | 0.040 |
Why?
|
| Retrospective Studies | 13 | 2015 | 77460 | 0.040 |
Why?
|
| Probability | 2 | 2003 | 2506 | 0.040 |
Why?
|
| Hyperlipidemias | 3 | 2005 | 789 | 0.040 |
Why?
|
| Antidepressive Agents | 3 | 2016 | 2838 | 0.040 |
Why?
|
| Nursing Research | 1 | 2020 | 77 | 0.040 |
Why?
|
| MicroRNAs | 1 | 2015 | 3751 | 0.040 |
Why?
|
| Social Isolation | 1 | 2002 | 365 | 0.040 |
Why?
|
| Arterial Occlusive Diseases | 1 | 2003 | 793 | 0.040 |
Why?
|
| Mice, Knockout | 2 | 2011 | 14561 | 0.040 |
Why?
|
| Apolipoprotein B-100 | 2 | 2013 | 148 | 0.040 |
Why?
|
| Observation | 1 | 2001 | 312 | 0.040 |
Why?
|
| Hemostasis | 1 | 2001 | 458 | 0.040 |
Why?
|
| Blood Donors | 1 | 2001 | 355 | 0.040 |
Why?
|
| 5,10-Methylenetetrahydrofolate Reductase (FADH2) | 1 | 1998 | 2 | 0.040 |
Why?
|
| Snoring | 1 | 2000 | 191 | 0.040 |
Why?
|
| Hormones | 1 | 2022 | 889 | 0.040 |
Why?
|
| Xanthophylls | 4 | 2000 | 96 | 0.040 |
Why?
|
| Arthritis, Rheumatoid | 2 | 2004 | 3712 | 0.040 |
Why?
|
| Lactase | 1 | 2018 | 69 | 0.040 |
Why?
|
| Lymph Nodes | 2 | 2000 | 3476 | 0.040 |
Why?
|
| Monitoring, Immunologic | 1 | 1998 | 100 | 0.040 |
Why?
|
| Antibodies | 1 | 2006 | 2460 | 0.040 |
Why?
|
| Endothelial Cells | 1 | 2011 | 3486 | 0.040 |
Why?
|
| Ferritins | 1 | 2001 | 590 | 0.040 |
Why?
|
| Sphingomyelins | 1 | 2018 | 106 | 0.040 |
Why?
|
| Glycoproteins | 1 | 2006 | 2266 | 0.040 |
Why?
|
| Starch | 1 | 2018 | 81 | 0.040 |
Why?
|
| Natriuretic Peptide, Brain | 1 | 2006 | 1572 | 0.040 |
Why?
|
| France | 1 | 1999 | 517 | 0.040 |
Why?
|
| Factor Analysis, Statistical | 4 | 2002 | 977 | 0.040 |
Why?
|
| Electrocoagulation | 1 | 1998 | 158 | 0.040 |
Why?
|
| Oxygen Isotopes | 1 | 2017 | 44 | 0.040 |
Why?
|
| Arsenic Poisoning | 1 | 1997 | 55 | 0.040 |
Why?
|
| Skinfold Thickness | 1 | 2017 | 162 | 0.040 |
Why?
|
| Deuterium | 1 | 2017 | 101 | 0.040 |
Why?
|
| Cattle | 1 | 2023 | 3922 | 0.040 |
Why?
|
| Intra-Abdominal Fat | 1 | 2023 | 591 | 0.040 |
Why?
|
| Periodicity | 1 | 1999 | 364 | 0.040 |
Why?
|
| Taq Polymerase | 2 | 2007 | 19 | 0.040 |
Why?
|
| Proinsulin | 1 | 2017 | 133 | 0.040 |
Why?
|
| Fabaceae | 1 | 2017 | 103 | 0.040 |
Why?
|
| Climate | 1 | 2018 | 147 | 0.040 |
Why?
|
| Probiotics | 1 | 2021 | 351 | 0.040 |
Why?
|
| Tissue Plasminogen Activator | 1 | 2004 | 1261 | 0.040 |
Why?
|
| Employment | 1 | 2004 | 1132 | 0.040 |
Why?
|
| Heart Arrest | 1 | 2007 | 1470 | 0.040 |
Why?
|
| Rats, Wistar | 1 | 2001 | 1892 | 0.040 |
Why?
|
| Cooperative Behavior | 2 | 2016 | 1504 | 0.040 |
Why?
|
| Registries | 3 | 2020 | 8091 | 0.040 |
Why?
|
| Intention | 1 | 2020 | 342 | 0.040 |
Why?
|
| Frail Elderly | 1 | 2022 | 693 | 0.040 |
Why?
|
| Food, Preserved | 1 | 2016 | 13 | 0.040 |
Why?
|
| Universities | 1 | 2022 | 951 | 0.040 |
Why?
|
| Least-Squares Analysis | 1 | 2017 | 379 | 0.040 |
Why?
|
| Nutrigenomics | 1 | 2016 | 23 | 0.040 |
Why?
|
| Eicosanoic Acids | 1 | 2015 | 15 | 0.030 |
Why?
|
| Adrenergic alpha-Antagonists | 1 | 1996 | 174 | 0.030 |
Why?
|
| Remission, Spontaneous | 1 | 2017 | 382 | 0.030 |
Why?
|
| Substance-Related Disorders | 3 | 2016 | 4257 | 0.030 |
Why?
|
| Immunoassay | 2 | 1998 | 752 | 0.030 |
Why?
|
| Amino Acids | 1 | 2022 | 1737 | 0.030 |
Why?
|
| Musa | 1 | 2016 | 12 | 0.030 |
Why?
|
| Demography | 1 | 2021 | 1655 | 0.030 |
Why?
|
| Depressive Disorder, Major | 1 | 2014 | 4639 | 0.030 |
Why?
|
| Diet, Reducing | 1 | 2019 | 462 | 0.030 |
Why?
|
| Stearic Acids | 1 | 2015 | 53 | 0.030 |
Why?
|
| Drug Therapy, Combination | 1 | 2006 | 6489 | 0.030 |
Why?
|
| Vulnerable Populations | 1 | 2021 | 686 | 0.030 |
Why?
|
| Isotope Labeling | 1 | 2017 | 406 | 0.030 |
Why?
|
| Finasteride | 1 | 1996 | 90 | 0.030 |
Why?
|
| Caffeic Acids | 1 | 2015 | 13 | 0.030 |
Why?
|
| Coumaric Acids | 1 | 2015 | 14 | 0.030 |
Why?
|
| Oxidoreductases | 1 | 1998 | 424 | 0.030 |
Why?
|
| Gene Expression Regulation, Neoplastic | 3 | 2015 | 8432 | 0.030 |
Why?
|
| Hesperidin | 1 | 2015 | 16 | 0.030 |
Why?
|
| Candy | 2 | 2012 | 37 | 0.030 |
Why?
|
| Multicenter Studies as Topic | 1 | 2020 | 1677 | 0.030 |
Why?
|
| Dentists | 3 | 2003 | 169 | 0.030 |
Why?
|
| Introns | 1 | 2018 | 992 | 0.030 |
Why?
|
| Violence | 1 | 2021 | 909 | 0.030 |
Why?
|
| Evaluation Studies as Topic | 1 | 1997 | 1681 | 0.030 |
Why?
|
| Minority Groups | 1 | 2023 | 1221 | 0.030 |
Why?
|
| Postoperative Complications | 5 | 1998 | 15297 | 0.030 |
Why?
|
| Palmitic Acid | 1 | 2015 | 154 | 0.030 |
Why?
|
| Cataract Extraction | 1 | 1999 | 481 | 0.030 |
Why?
|
| Thioredoxin Reductase 1 | 1 | 2014 | 32 | 0.030 |
Why?
|
| Single Person | 1 | 2014 | 33 | 0.030 |
Why?
|
| Cholesterol, Dietary | 3 | 2003 | 231 | 0.030 |
Why?
|
| Troponin I | 1 | 1999 | 619 | 0.030 |
Why?
|
| Sunlight | 2 | 2011 | 325 | 0.030 |
Why?
|
| Smell | 1 | 2016 | 244 | 0.030 |
Why?
|
| Myocardium | 1 | 2007 | 4772 | 0.030 |
Why?
|
| Ankle Brachial Index | 1 | 2015 | 154 | 0.030 |
Why?
|
| Canada | 1 | 2020 | 2065 | 0.030 |
Why?
|
| Receptors, Androgen | 1 | 2000 | 1058 | 0.030 |
Why?
|
| Glucose | 2 | 2023 | 4398 | 0.030 |
Why?
|
| Disease Susceptibility | 1 | 2021 | 1782 | 0.030 |
Why?
|
| Fractures, Bone | 2 | 1998 | 1947 | 0.030 |
Why?
|
| Tuna | 2 | 2004 | 19 | 0.030 |
Why?
|
| Fissure in Ano | 1 | 1993 | 13 | 0.030 |
Why?
|
| Troponin T | 1 | 1999 | 754 | 0.030 |
Why?
|
| Analgesics | 2 | 2006 | 1040 | 0.030 |
Why?
|
| Lymphoma, Non-Hodgkin | 1 | 2001 | 1381 | 0.030 |
Why?
|
| Fatty Acids, Nonesterified | 1 | 2015 | 402 | 0.030 |
Why?
|
| Myocardial Contraction | 1 | 1999 | 1579 | 0.030 |
Why?
|
| Single-Blind Method | 3 | 2004 | 1590 | 0.030 |
Why?
|
| Physicians | 1 | 2011 | 4567 | 0.030 |
Why?
|
| Cataract | 1 | 1999 | 834 | 0.030 |
Why?
|
| Gestational Age | 2 | 2018 | 3493 | 0.030 |
Why?
|
| Brachial Artery | 1 | 2015 | 369 | 0.030 |
Why?
|
| Attention | 1 | 2024 | 2397 | 0.030 |
Why?
|
| Pancreatic Neoplasms | 2 | 2004 | 5263 | 0.030 |
Why?
|
| Fetal Blood | 1 | 2000 | 1318 | 0.030 |
Why?
|
| Iron | 3 | 2001 | 1774 | 0.030 |
Why?
|
| Plant Leaves | 1 | 2013 | 143 | 0.030 |
Why?
|
| Galectins | 1 | 2016 | 268 | 0.030 |
Why?
|
| Proanthocyanidins | 1 | 2012 | 20 | 0.030 |
Why?
|
| Selenoproteins | 1 | 2014 | 216 | 0.030 |
Why?
|
| Marriage | 1 | 2014 | 339 | 0.030 |
Why?
|
| Steroid Hydroxylases | 1 | 2012 | 96 | 0.030 |
Why?
|
| Vasectomy | 1 | 1993 | 52 | 0.030 |
Why?
|
| Neutron Activation Analysis | 1 | 2012 | 35 | 0.030 |
Why?
|
| Quality Control | 2 | 2011 | 841 | 0.030 |
Why?
|
| Abortion, Induced | 1 | 2018 | 458 | 0.030 |
Why?
|
| Pyrus | 1 | 2012 | 12 | 0.030 |
Why?
|
| Australia | 1 | 2016 | 1167 | 0.030 |
Why?
|
| Spain | 1 | 2014 | 465 | 0.030 |
Why?
|
| Carrier Proteins | 1 | 2006 | 5023 | 0.030 |
Why?
|
| Cost of Illness | 1 | 2002 | 1860 | 0.030 |
Why?
|
| Melanoma | 1 | 2011 | 5511 | 0.030 |
Why?
|
| Regulatory Sequences, Nucleic Acid | 1 | 2016 | 794 | 0.030 |
Why?
|
| Patient Education as Topic | 1 | 2002 | 2278 | 0.030 |
Why?
|
| Republic of Korea | 1 | 2014 | 538 | 0.030 |
Why?
|
| Temperature | 1 | 1999 | 2204 | 0.030 |
Why?
|
| Poverty Areas | 1 | 2014 | 275 | 0.030 |
Why?
|
| Basic Helix-Loop-Helix Leucine Zipper Transcription Factors | 1 | 2014 | 315 | 0.030 |
Why?
|
| Fatty Acid Desaturases | 1 | 2012 | 102 | 0.030 |
Why?
|
| Heme | 1 | 1994 | 307 | 0.030 |
Why?
|
| Adaptation, Psychological | 1 | 2003 | 2575 | 0.030 |
Why?
|
| Angina Pectoris | 1 | 2016 | 977 | 0.030 |
Why?
|
| Intestinal Obstruction | 1 | 1995 | 423 | 0.030 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2006 | 3255 | 0.030 |
Why?
|
| Biopsy, Needle | 1 | 1997 | 1641 | 0.020 |
Why?
|
| Absorptiometry, Photon | 1 | 2017 | 1725 | 0.020 |
Why?
|
| Oxidoreductases Acting on CH-CH Group Donors | 1 | 2012 | 167 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 5 | 1 | 2013 | 403 | 0.020 |
Why?
|
| Signal Transduction | 2 | 2012 | 23404 | 0.020 |
Why?
|
| Infant, Premature | 1 | 2020 | 2045 | 0.020 |
Why?
|
| Oral Health | 1 | 1996 | 474 | 0.020 |
Why?
|
| Platelet Aggregation Inhibitors | 1 | 2004 | 3070 | 0.020 |
Why?
|
| Fluorescence | 1 | 2013 | 751 | 0.020 |
Why?
|
| Diffusion of Innovation | 1 | 2016 | 725 | 0.020 |
Why?
|
| Greece | 3 | 1997 | 344 | 0.020 |
Why?
|
| Genetic Testing | 1 | 2003 | 3444 | 0.020 |
Why?
|
| Albuminuria | 1 | 2015 | 681 | 0.020 |
Why?
|
| Parent-Child Relations | 1 | 2015 | 747 | 0.020 |
Why?
|
| Blood Proteins | 1 | 2016 | 1124 | 0.020 |
Why?
|
| Colorimetry | 1 | 2011 | 147 | 0.020 |
Why?
|
| Vasodilation | 1 | 2015 | 944 | 0.020 |
Why?
|
| Kaplan-Meier Estimate | 2 | 2012 | 6539 | 0.020 |
Why?
|
| Hydrogenation | 1 | 2010 | 21 | 0.020 |
Why?
|
| Brain-Derived Neurotrophic Factor | 1 | 2014 | 604 | 0.020 |
Why?
|
| Genome, Human | 1 | 2003 | 4420 | 0.020 |
Why?
|
| Oncogene Proteins, Fusion | 1 | 2018 | 1581 | 0.020 |
Why?
|
| Carcinoma, Ductal, Breast | 1 | 1998 | 1100 | 0.020 |
Why?
|
| Phylogeny | 1 | 2018 | 2804 | 0.020 |
Why?
|
| Mutagenesis, Insertional | 1 | 2013 | 655 | 0.020 |
Why?
|
| Colectomy | 1 | 1995 | 680 | 0.020 |
Why?
|
| Appendectomy | 1 | 1993 | 401 | 0.020 |
Why?
|
| Carcinoma | 2 | 1999 | 2375 | 0.020 |
Why?
|
| Isomerism | 1 | 2010 | 201 | 0.020 |
Why?
|
| Postal Service | 1 | 1990 | 96 | 0.020 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2001 | 8300 | 0.020 |
Why?
|
| Memory Disorders | 1 | 2017 | 1186 | 0.020 |
Why?
|
| Colonoscopy | 4 | 2004 | 1367 | 0.020 |
Why?
|
| Mastectomy | 1 | 1998 | 1793 | 0.020 |
Why?
|
| Carbonated Beverages | 1 | 2011 | 214 | 0.020 |
Why?
|
| Apoptosis Regulatory Proteins | 1 | 2015 | 1157 | 0.020 |
Why?
|
| Risk-Taking | 1 | 1995 | 986 | 0.020 |
Why?
|
| Intestinal Diseases | 1 | 1994 | 530 | 0.020 |
Why?
|
| Interleukin-18 | 1 | 2011 | 249 | 0.020 |
Why?
|
| Interpersonal Relations | 1 | 2017 | 1425 | 0.020 |
Why?
|
| Depressive Disorder | 1 | 2002 | 3747 | 0.020 |
Why?
|
| Gene Regulatory Networks | 1 | 2018 | 1707 | 0.020 |
Why?
|
| Electrocardiography | 2 | 2001 | 6442 | 0.020 |
Why?
|
| Down-Regulation | 1 | 2016 | 3001 | 0.020 |
Why?
|
| Consensus | 1 | 2018 | 2960 | 0.020 |
Why?
|
| Cytokines | 1 | 2004 | 7323 | 0.020 |
Why?
|
| Receptors, Aryl Hydrocarbon | 1 | 2011 | 209 | 0.020 |
Why?
|
| Vitis | 1 | 2008 | 18 | 0.020 |
Why?
|
| Attitude of Health Personnel | 1 | 2003 | 3841 | 0.020 |
Why?
|
| Muscle Strength | 1 | 2013 | 592 | 0.020 |
Why?
|
| Mexico | 1 | 2011 | 689 | 0.020 |
Why?
|
| Lung Neoplasms | 2 | 2005 | 13104 | 0.020 |
Why?
|
| Hernia, Inguinal | 1 | 1991 | 210 | 0.020 |
Why?
|
| Public Policy | 1 | 1993 | 572 | 0.020 |
Why?
|
| Pregnancy Trimester, Second | 1 | 2011 | 732 | 0.020 |
Why?
|
| Base Sequence | 2 | 2013 | 12797 | 0.020 |
Why?
|
| Principal Component Analysis | 1 | 2011 | 940 | 0.020 |
Why?
|
| Biostatistics | 1 | 2010 | 161 | 0.020 |
Why?
|
| Metabolic Networks and Pathways | 1 | 2013 | 783 | 0.020 |
Why?
|
| Herpes Labialis | 1 | 1988 | 29 | 0.020 |
Why?
|
| Epistasis, Genetic | 1 | 2010 | 365 | 0.020 |
Why?
|
| Immunohistochemistry | 2 | 2018 | 11366 | 0.020 |
Why?
|
| Quebec | 1 | 2008 | 134 | 0.020 |
Why?
|
| Monte Carlo Method | 1 | 2013 | 1254 | 0.020 |
Why?
|
| Ether-A-Go-Go Potassium Channels | 1 | 2007 | 70 | 0.020 |
Why?
|
| Anesthesia, General | 1 | 1995 | 1171 | 0.020 |
Why?
|
| Workload | 1 | 2014 | 849 | 0.020 |
Why?
|
| Anxiety | 1 | 2002 | 4293 | 0.020 |
Why?
|
| Qualitative Research | 1 | 2016 | 2682 | 0.020 |
Why?
|
| KCNQ1 Potassium Channel | 1 | 2007 | 104 | 0.020 |
Why?
|
| Social Environment | 1 | 2013 | 1022 | 0.020 |
Why?
|
| Pain, Postoperative | 2 | 1994 | 1643 | 0.020 |
Why?
|
| Self Care | 1 | 2013 | 786 | 0.020 |
Why?
|
| Functional Laterality | 1 | 1994 | 2290 | 0.020 |
Why?
|
| Pregnancy Trimester, First | 1 | 2011 | 853 | 0.020 |
Why?
|
| Heart Conduction System | 1 | 2013 | 1047 | 0.020 |
Why?
|
| Mass Screening | 2 | 2008 | 5253 | 0.020 |
Why?
|
| Lymphatic Metastasis | 3 | 2000 | 2924 | 0.020 |
Why?
|
| Host-Pathogen Interactions | 1 | 2016 | 1480 | 0.020 |
Why?
|
| Potassium Channels, Voltage-Gated | 1 | 2007 | 142 | 0.020 |
Why?
|
| Mice | 2 | 2011 | 81201 | 0.020 |
Why?
|
| Intubation, Intratracheal | 1 | 1995 | 1364 | 0.020 |
Why?
|
| Surgical Procedures, Operative | 2 | 1997 | 1877 | 0.020 |
Why?
|
| Child Behavior | 1 | 2013 | 839 | 0.020 |
Why?
|
| Health Policy | 1 | 2019 | 2661 | 0.020 |
Why?
|
| Phospholipases A2 | 1 | 2007 | 203 | 0.020 |
Why?
|
| Glomerular Filtration Rate | 2 | 2006 | 2166 | 0.020 |
Why?
|
| Structure-Activity Relationship | 1 | 2012 | 3130 | 0.020 |
Why?
|
| Brain | 1 | 2013 | 26388 | 0.020 |
Why?
|
| Gene Dosage | 1 | 2011 | 1252 | 0.020 |
Why?
|
| Oxygen Consumption | 1 | 2013 | 1868 | 0.020 |
Why?
|
| Coronary Artery Bypass | 1 | 2016 | 2288 | 0.020 |
Why?
|
| Echocardiography | 1 | 1999 | 5099 | 0.020 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2013 | 35425 | 0.020 |
Why?
|
| Stroke Volume | 1 | 1999 | 5006 | 0.020 |
Why?
|
| Intracranial Hemorrhages | 1 | 2012 | 855 | 0.020 |
Why?
|
| Digestive System Neoplasms | 1 | 2006 | 86 | 0.020 |
Why?
|
| CCAAT-Enhancer-Binding Protein-alpha | 1 | 2006 | 130 | 0.020 |
Why?
|
| Enzyme Inhibitors | 1 | 1996 | 3799 | 0.020 |
Why?
|
| Neoplasm Proteins | 1 | 1998 | 3707 | 0.020 |
Why?
|
| Science | 1 | 2008 | 241 | 0.020 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2018 | 3595 | 0.020 |
Why?
|
| Isoenzymes | 2 | 2001 | 1728 | 0.020 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2020 | 3922 | 0.020 |
Why?
|
| Chromium Compounds | 1 | 2004 | 7 | 0.020 |
Why?
|
| Lower Extremity | 1 | 2013 | 1158 | 0.020 |
Why?
|
| Biopsy | 1 | 1997 | 6755 | 0.020 |
Why?
|
| Albumins | 1 | 2007 | 568 | 0.020 |
Why?
|
| Glucose Tolerance Test | 1 | 2008 | 1151 | 0.020 |
Why?
|
| Ultraviolet Rays | 2 | 2006 | 1060 | 0.020 |
Why?
|
| Self Concept | 1 | 1990 | 1025 | 0.020 |
Why?
|
| Drug Evaluation | 1 | 2006 | 647 | 0.020 |
Why?
|
| Rats | 1 | 2001 | 24252 | 0.020 |
Why?
|
| Meperidine | 2 | 1994 | 38 | 0.020 |
Why?
|
| Nitric Oxide | 1 | 2013 | 2132 | 0.020 |
Why?
|
| Rectal Neoplasms | 1 | 1994 | 1205 | 0.020 |
Why?
|
| Disease | 1 | 2010 | 680 | 0.020 |
Why?
|
| Hyperplasia | 2 | 2000 | 1185 | 0.010 |
Why?
|
| Amino Acid Substitution | 1 | 2009 | 1793 | 0.010 |
Why?
|
| Stents | 1 | 2016 | 3282 | 0.010 |
Why?
|
| Skin Pigmentation | 1 | 2006 | 282 | 0.010 |
Why?
|
| Repressor Proteins | 1 | 2015 | 3024 | 0.010 |
Why?
|
| Coronary Vessels | 1 | 2015 | 3107 | 0.010 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2014 | 2917 | 0.010 |
Why?
|
| Laparoscopy | 1 | 2016 | 2150 | 0.010 |
Why?
|
| Jaw, Edentulous, Partially | 1 | 2004 | 85 | 0.010 |
Why?
|
| Leukocyte Count | 1 | 2007 | 1588 | 0.010 |
Why?
|
| Jaw, Edentulous | 1 | 2004 | 93 | 0.010 |
Why?
|
| alpha-Tocopherol | 1 | 2003 | 127 | 0.010 |
Why?
|
| Solar System | 1 | 2002 | 12 | 0.010 |
Why?
|
| Luteolin | 1 | 2002 | 12 | 0.010 |
Why?
|
| Calorimetry | 1 | 2003 | 126 | 0.010 |
Why?
|
| Exons | 1 | 2009 | 2439 | 0.010 |
Why?
|
| Epigenesis, Genetic | 1 | 2016 | 3646 | 0.010 |
Why?
|
| Body Burden | 1 | 2003 | 158 | 0.010 |
Why?
|
| Dental Restoration, Permanent | 1 | 2003 | 127 | 0.010 |
Why?
|
| Acute Disease | 2 | 2005 | 7147 | 0.010 |
Why?
|
| Coronary Angiography | 1 | 2014 | 4576 | 0.010 |
Why?
|
| Disease-Free Survival | 1 | 2012 | 6896 | 0.010 |
Why?
|
| Patient Readmission | 1 | 2016 | 3116 | 0.010 |
Why?
|
| Cadmium | 1 | 2002 | 212 | 0.010 |
Why?
|
| Chlorides | 1 | 2004 | 667 | 0.010 |
Why?
|
| Minerals | 1 | 2003 | 275 | 0.010 |
Why?
|
| New York City | 1 | 2003 | 710 | 0.010 |
Why?
|
| Biological Availability | 1 | 2002 | 397 | 0.010 |
Why?
|
| Hawaii | 1 | 2001 | 105 | 0.010 |
Why?
|
| Reference Standards | 1 | 2005 | 1025 | 0.010 |
Why?
|
| Protein Isoforms | 1 | 2006 | 1730 | 0.010 |
Why?
|
| Cardiotonic Agents | 1 | 2004 | 535 | 0.010 |
Why?
|
| Chemoprevention | 1 | 2003 | 319 | 0.010 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 2008 | 1222 | 0.010 |
Why?
|
| Stereoisomerism | 1 | 2001 | 624 | 0.010 |
Why?
|
| Spinacia oleracea | 1 | 1999 | 12 | 0.010 |
Why?
|
| History, 20th Century | 1 | 2008 | 2740 | 0.010 |
Why?
|
| Interleukins | 1 | 2004 | 791 | 0.010 |
Why?
|
| Mutation | 2 | 2009 | 29786 | 0.010 |
Why?
|
| Environment | 1 | 2006 | 1123 | 0.010 |
Why?
|
| Appetite | 1 | 2001 | 243 | 0.010 |
Why?
|
| Grief | 1 | 2002 | 248 | 0.010 |
Why?
|
| Morphine | 2 | 1994 | 657 | 0.010 |
Why?
|
| Rectum | 2 | 1995 | 904 | 0.010 |
Why?
|
| Myoglobin | 1 | 1999 | 160 | 0.010 |
Why?
|
| Allied Health Personnel | 1 | 2000 | 162 | 0.010 |
Why?
|
| Muscle Tonus | 1 | 1998 | 81 | 0.010 |
Why?
|
| Arteries | 1 | 2003 | 1119 | 0.010 |
Why?
|
| Sweden | 1 | 2001 | 1341 | 0.010 |
Why?
|
| Hepatocyte Growth Factor | 1 | 1999 | 270 | 0.010 |
Why?
|
| Suburban Population | 1 | 1998 | 55 | 0.010 |
Why?
|
| Algorithms | 1 | 2018 | 13882 | 0.010 |
Why?
|
| Genetic Linkage | 1 | 2003 | 2421 | 0.010 |
Why?
|
| Calcium Oxalate | 1 | 1998 | 74 | 0.010 |
Why?
|
| Swimming | 1 | 1999 | 205 | 0.010 |
Why?
|
| Teaching | 2 | 1997 | 1174 | 0.010 |
Why?
|
| Exudates and Transudates | 1 | 1998 | 172 | 0.010 |
Why?
|
| Buttocks | 1 | 1998 | 110 | 0.010 |
Why?
|
| Bicycling | 1 | 1999 | 176 | 0.010 |
Why?
|
| Fluid Therapy | 2 | 1992 | 593 | 0.010 |
Why?
|
| Fluorescent Antibody Technique, Indirect | 1 | 1998 | 429 | 0.010 |
Why?
|
| Axilla | 1 | 1999 | 597 | 0.010 |
Why?
|
| Virginia | 1 | 1997 | 121 | 0.010 |
Why?
|
| Creatine Kinase | 1 | 1999 | 694 | 0.010 |
Why?
|
| Dental Health Surveys | 1 | 1996 | 43 | 0.010 |
Why?
|
| Substance Abuse, Intravenous | 1 | 2001 | 525 | 0.010 |
Why?
|
| DMF Index | 1 | 1996 | 90 | 0.010 |
Why?
|
| District of Columbia | 1 | 1996 | 157 | 0.010 |
Why?
|
| Sequence Analysis, DNA | 1 | 2007 | 4805 | 0.010 |
Why?
|
| Genetic Heterogeneity | 1 | 1999 | 733 | 0.010 |
Why?
|
| Sympathetic Nervous System | 1 | 1998 | 513 | 0.010 |
Why?
|
| Chin | 1 | 1995 | 38 | 0.010 |
Why?
|
| Nitrogen | 1 | 1997 | 344 | 0.010 |
Why?
|
| Nuclear Family | 1 | 1996 | 318 | 0.010 |
Why?
|
| Thyroid Cartilage | 1 | 1995 | 42 | 0.010 |
Why?
|
| Necrosis | 1 | 2000 | 1643 | 0.010 |
Why?
|
| HIV Infections | 1 | 2001 | 16715 | 0.010 |
Why?
|
| Hysterectomy, Vaginal | 1 | 1994 | 37 | 0.010 |
Why?
|
| Muscle, Smooth | 1 | 1998 | 934 | 0.010 |
Why?
|
| Running | 1 | 1999 | 480 | 0.010 |
Why?
|
| Phosphates | 1 | 1998 | 785 | 0.010 |
Why?
|
| Mathematical Computing | 1 | 1994 | 147 | 0.010 |
Why?
|
| Protein Binding | 1 | 2006 | 9384 | 0.010 |
Why?
|
| Cephalometry | 1 | 1995 | 382 | 0.010 |
Why?
|
| Lymph Node Excision | 1 | 2000 | 1262 | 0.010 |
Why?
|
| Urination Disorders | 1 | 1994 | 241 | 0.010 |
Why?
|
| Anus Diseases | 1 | 1993 | 59 | 0.010 |
Why?
|
| Sigmoidoscopy | 1 | 1994 | 156 | 0.010 |
Why?
|
| Salivary Gland Neoplasms | 1 | 1997 | 298 | 0.010 |
Why?
|
| Molecular Sequence Data | 1 | 2006 | 18111 | 0.010 |
Why?
|
| Mouth | 1 | 1995 | 374 | 0.010 |
Why?
|
| Occupational Exposure | 1 | 2003 | 1793 | 0.010 |
Why?
|
| Tongue | 1 | 1995 | 406 | 0.010 |
Why?
|
| Rectal Diseases | 1 | 1993 | 143 | 0.010 |
Why?
|
| Injections, Intramuscular | 1 | 1993 | 552 | 0.010 |
Why?
|
| Transcription, Genetic | 1 | 2006 | 7721 | 0.010 |
Why?
|
| Neoplasm Invasiveness | 1 | 2000 | 3616 | 0.010 |
Why?
|
| New York | 1 | 1994 | 886 | 0.010 |
Why?
|
| Patient Selection | 1 | 2003 | 4216 | 0.010 |
Why?
|
| Visual Acuity | 1 | 2000 | 2530 | 0.010 |
Why?
|
| Cluster Analysis | 1 | 1998 | 2715 | 0.010 |
Why?
|
| Paternal Age | 1 | 1991 | 84 | 0.010 |
Why?
|
| Isotonic Solutions | 1 | 1991 | 119 | 0.010 |
Why?
|
| Posture | 1 | 1995 | 958 | 0.010 |
Why?
|
| Mental Disorders | 1 | 2011 | 6598 | 0.010 |
Why?
|
| Mice, Inbred C57BL | 1 | 2009 | 21833 | 0.010 |
Why?
|
| Pruritus | 1 | 1993 | 361 | 0.010 |
Why?
|
| Medical Records | 1 | 1996 | 1413 | 0.010 |
Why?
|
| Tumor Cells, Cultured | 1 | 1998 | 6313 | 0.010 |
Why?
|
| Receptors, Estrogen | 1 | 1998 | 2190 | 0.010 |
Why?
|
| Abscess | 1 | 1993 | 607 | 0.010 |
Why?
|
| Head | 1 | 1995 | 880 | 0.010 |
Why?
|
| Infusions, Intravenous | 1 | 1994 | 2274 | 0.010 |
Why?
|
| Guidelines as Topic | 1 | 1996 | 1405 | 0.010 |
Why?
|
| Laryngoscopy | 1 | 1995 | 710 | 0.010 |
Why?
|
| Surgical Flaps | 1 | 1998 | 1640 | 0.010 |
Why?
|
| Liver | 1 | 2005 | 7475 | 0.010 |
Why?
|
| Hyperglycemia | 1 | 1998 | 1373 | 0.010 |
Why?
|
| Breast | 1 | 1998 | 1970 | 0.010 |
Why?
|
| Data Interpretation, Statistical | 1 | 1999 | 2716 | 0.010 |
Why?
|
| Reactive Oxygen Species | 1 | 1996 | 2076 | 0.010 |
Why?
|
| Wisconsin | 1 | 1988 | 124 | 0.000 |
Why?
|
| Maternal Age | 1 | 1991 | 802 | 0.000 |
Why?
|
| Anesthesia, Spinal | 1 | 1991 | 269 | 0.000 |
Why?
|
| Prostatectomy | 1 | 1996 | 1890 | 0.000 |
Why?
|
| Practice Guidelines as Topic | 1 | 2004 | 7282 | 0.000 |
Why?
|
| Intraoperative Care | 1 | 1991 | 767 | 0.000 |
Why?
|
| Neoplasm Metastasis | 1 | 1997 | 4851 | 0.000 |
Why?
|
| Gastrointestinal Hemorrhage | 1 | 1993 | 1131 | 0.000 |
Why?
|
| Dental Care | 1 | 1988 | 262 | 0.000 |
Why?
|
| Combined Modality Therapy | 1 | 1996 | 8642 | 0.000 |
Why?
|
| Societies, Medical | 1 | 1996 | 3743 | 0.000 |
Why?
|
| Thyroid Neoplasms | 1 | 1997 | 2282 | 0.000 |
Why?
|
| Pediatrics | 1 | 1996 | 3475 | 0.000 |
Why?
|
| Medicare | 1 | 1997 | 6566 | 0.000 |
Why?
|
| Pain | 1 | 1993 | 4988 | 0.000 |
Why?
|
| Analgesics, Opioid | 1 | 1992 | 3677 | 0.000 |
Why?
|